Print This Page
Share this page: More

In the Media

Coverage of department activities and its faculty in the general media.



This is a scientifically determined playlist for tripping - Inverse
The swelling soundscape surrounding you is the artistry of psychologist Bill Richards, Ph.D., who developed the playlist specifically for your psychedelic trip. Richards works with Roland Griffiths’s lab at Johns Hopkins University, where patients get more than just conventional medicine.

There Once Was a Girl: Against the false narratives of anorexia. - Slate
Though their effect is hard to quantify, “a lot of war stories and memoirs out there … glorify the specialness and suffering of anorexia,” says Dr. Angela Guarda, director of the Johns Hopkins Eating Disorders Program. “Anecdotally, patients often acknowledge that these writings romanticize the disorder,” and that “reading them can be triggering and worsen their ED.”

Fundraising stamps will benefit Alzheimer's disease research (video) - WBAL-TV
The United States Postal Service is doing its part to find a cure for Alzheimer's disease. Officials held a ceremony at Johns Hopkins [Bayview Medical Center] to unveil the Alzheimer's semi postal fund-raising stamp. It will benefit the Department of Health and Human Services and their efforts to find a cure


USPS dedicates Alzheimer’s fundraising stamp - WCBD News 2
Postmaster General Megan J. Brennan dedicated a stamp today to fund research to help find a cure for one of the top 10 leading causes of death — Alzheimer’s. The first-day-of-issue dedication ceremony for the Alzheimer’s Semipostal Fundraising stamp took place at Johns Hopkins Bayview Medical Center in Baltimore.

Redefining age (audio; 21:35) - WYPR-FM
[The show's host says to author Ann Kaiser Stearns]: You write that there's a learning curve to caregiving, and you quote Dr. Ray DePaulo, the former head of psychiatry at Johns Hopkins Medicine, about ways to avoid what you call "the catastrophic reaction."

Self-harm rises sharply among tween and young teen girls, study shows - Los Angeles Times
In a November 2016 study chronicling the rise in depression among young girls, a team led by Johns Hopkins psychiatrist Ramin Mojtabai noted that adolescent girls appear to be coming under increasing stress. As an example, Mojtabai and his team wrote that cyberbullying may have increased more dramatically among girls than boys.

What is ephebophilia? Some say attraction to teens is not the same as paedophilia - International Business Times
"The average man refrains from sex with a child not only because he's a moral person but also because a child does not tempt him sexually," said [Fred] Berlin, founder of the Sexual Disorders Clinic at the Johns Hopkins Hospital. "Ephebophilia is a condition in which a person is attracted not to prepubescent children but to children or adolescents around the time of puberty, basically teenagers. Most men can find adolescents attractive sexually, although, of course, that doesn't mean they're going to act on it."

A change of mind: Scientists are learning to predict psychosis years in advance — and possibly prevent -The Scientist
[W]hy does one person with these early signs develop psychosis and not another? Brain studies have yielded some clues. In healthy kids, "the brain dynamically changes" during adolescence, says Akira Sawa, a psychiatrist at Johns Hopkins University in Baltimore, Maryland. 

Why can’t Lucile Packard Children’s Hospital Stanford offer care for mentally ill kids? - San Jose Mercury News
Model inpatient youth psychiatric care is provided at other U.S. hospitals, including Johns Hopkins, which delivers inpatient diagnosis and treatment for ages 5 to 17.

The U.S. Postal Service is taking on Alzheimer’s with a new stamp - Washington Post
The first-class stamp, which shows someone placing a hand on the shoulder of an elderly woman, hints at the hope and companionship that caregivers, researchers and an aware public can bring.... The stamp will be dedicated at a ceremony at the Memory & Alzheimer’s Treatment Center at Johns Hopkins’s Bayview campus in Baltimore on Nov. 30.

This doctor might have the answer to the fentanyl crisis - Vancouver magazine
The last five or so years have seen a resurgence of clinical interest in psychedelics — the old hippie drugs that can open what Johns Hopkins psychologist Roland Griffiths calls a “spiritual window” through which deep insight might flow.

Why powerful men make women watch them masturbate - San Diego Union-Tribune
Driven by strong, recurrent sexual urges, exhibitionists act on a self-deceptive fantasy that the witness might enjoy the experience, said Frederick Berlin, the director of the Sex and Gender Clinic at Johns Hopkins Medicine in Baltimore. When the witness responds negatively, the exhibitionist often feels intense regret, shame and self-disgust, said Berlin, an associate professor of psychiatry and behavioral sciences.​

How caring for a sick pet can raise your risk of depression - U.S. News & World Report
Caring for a sick pet has many parallels with providing care to human loved one, says Dr. Susan W. Lehmann, clinical director of the division of geriatric psychiatry and neuropsychiatry and director of the Geriatric Psychiatry Day Hospital at the Johns Hopkins University School of Medicine.


Monthly shot for opioid addiction might be as effective as daily medication - Healthline News
“One of the biggest risk factors for people when they detox is that in the 30 days after, they are no longer physically dependent on opiates. They have a very high risk of relapsing to opiates,” Kelly Dunn, PhD, an associate professor of psychiatry and behavioral sciences at Johns Hopkins Medicine, told Healthline.

The Most Lethal Means: Guns and Suicide – WYPR
Paul Nestadt, MD, postdoctoral fellow, is interviewed.  His recent research paper compares urban and rural suicide rates in Maryland. Ramin Mojtabai, MD and Patrick Triplett are also authors on that paper. 

How to talk to kids about the deadly New York City truck attack - ABC News
Joan Kaufman, a professor of psychiatry and child and adolescent psychiatry at Johns Hopkins School of Medicine, said having conversations about Tuesday’s attack with children of all ages -- including as young as preschool -- is a must for parents. “There might be the feeling they want to protect their kids and not talk to them about it, but children are going to find out,” she said. “It’s better if information about the event comes from the parents.”

The caffeine 'detox': How and why to cut back on your daily fix - CNN
"Caffeine is the most commonly consumed psychoactive drug," said Mary M. Sweeney, an instructor who researches caffeine's effects on individuals in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. "When we consume caffeine, it has positive effects on mood and alertness, and people like these beneficial effects."

Why we all have clutter and how to get rid of it - Psych Central
I do not feel equipped to give advice here when I’m tripping over piles of books on the floor of my bedroom. But I like the behavioral tips offered by Dr. Gerald Nestadt, director of the Johns Hopkins OCD clinic, in an issue of The Johns Hopkins Depression & Anxiety Bulletin.

Betty Jarratt, psychiatric liaison at Hopkins Hospital - Baltimore Sun
Betty Jarratt, a former psychiatric liaison at Johns Hopkins Hospital … died Thursday of respiratory failure at The Cedars, a Portland, Maine, retirement community. She was 94…. After Ms. Jarratt was divorced in 1966, she moved to Baltimore when she was selected by Hopkins Hospital to work with Dr. Joel Elkes, a noted expert on brain chemistry and early psychiatric drugs.

Will psychedelic therapy transform mental health care? - NBC News
In 2016 … a Johns Hopkins study and a concurrent New York University study found that about 80 percent of cancer patients showed clinically significant decreases in depressed mood and anxiety even six months after receiving one to two psilocybin treatments.


You can't cure depression by working out – Vice
"People experience anxiety, no doubt about it, but [most] don't have an anxiety disorder," says Jennifer Payne, an associate professor of psychiatry and behavioral science at Johns Hopkins School of Medicine. "Yoga is fabulous and can be great for anxiety, but it's not going to cure an anxiety disorder."

Interrupted sleep can prevent slow wave sleep and wreck your mood  -Today
“When sleep is disrupted several times during the night you may never get to slow wave sleep,” explains the study’s lead author, Patrick Finan, an assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. And that, Finan says, may be what makes all the difference in a person’s mood the next day.

Parental age ups rate of new mutations passed to children  - Spectrum
The findings provide one possible explanation for the increased risk of autism among children born to older parents. But it is still unclear how much of the risk the increased mutation rate explains, says Daniel Weinberger, professor of psychiatry, neurology and neuroscience at Johns Hopkins University in Baltimore, who was not involved in the study.

Matter of Fact: State of Addiction (video; 33:28) - WBAL-TV
This primetime, one-hour special that addresses America's opioid epidemic includes the story of a Baltimore heroin user who has been treated at, among other places, Johns Hopkins’ Broadway Center for Addiction. A woman who has been supportive of his recovery treatment says the Broadway Center “has really taken the time to diagnose him and treat him as a person.”

Psychiatric services from pages to practice (audio; 9:15) - Psychiatric Services
The hosts of this podcast discuss a recent report by Stanislav Spivak, medical director, Johns Hopkins’ Mobile Treatment Services of Community Psychiatry, on the effects of direct-to-consumer advertising on medication adherence.

America’s Opioid Epidemic - Search for Solutions – The Hill
A panel discussion featuring Ken Stoller, M.D. Director of the JH Broadway Center for Addiction

Changing the dialogue about mental illness in black community - Afro American
Resources are available. Maryland boasts a higher doctor to patient ratio than the national average. Organizations like The Simon Life and Wellness Center and All Walks of Life, among others, cater to Baltimore’s underserved populations. Inpatient and outpatient programs that accept Medicaid are available at Johns Hopkins Hospital and the University of Maryland Medical Center.

Alzheimer’s linked to low brain chemical count​ - National Enquirer
Research carried out by Gwenn Smith, a psychiatry professor at the Johns Hopkins University School of Medicine, examined the levels of serotonin in the brains of 56 participants.... Scans found participants with [mild cognitive impairment] had up to 38 percent less serotonin than healthy participants of the same age. The findings suggest the brain chemical may drive the illness rather than simply being its by-product.

2 scientists are locked in a race to develop a groundbreaking vaccine for heroin, but it might not be a 'magic bullet' - Business Insider
While the Obama administration made administrative changes to increase the number of prescribers administering buprenorphine last year, a study conducted by the Johns Hopkins School of Medicine earlier this year found that only 44% of physicians who had obtained a waiver to prescribe buprenorphine were doing so at full capacity.

Hobart man seeks 'chemical castration' instead of prison time - Chicago Tribune
[Michael] Bessigano asked that the court consider the time he's spent incarcerated and release him on the condition that he undergoes chemical hormone treatments using the drug Depo-Lupron, that would reduce his testosterone levels.... Fred Berlin, an associate professor at the Johns Hopkins University School of Medicine, evaluated Bessigano during a July interview and wrote in a letter that the hormone treatment could prove effective.

The Secret To Chronic Happiness As You Age - Kaiser Health News
“You have to be willing to accept your new reality — and move forward,” said Dr. Susan Lehmann, director of the geriatric psychiatry day program at Johns Hopkins University School of Medicine. “Aim to have the best life you can at where you are right now.”


Helping children exposed to trauma recover (audio) - KJZZ-FM (Tempe, Ariz.)
How do violent and traumatic experiences in childhood affect ... kids [in war-torn areas] as they grow up, and how can experts help them? With me to help answer those questions is Dr. Carolina Vidal. She's an assistant professor of psychiatry at Johns Hopkins University, specializing in child and adolescent psychiatry.

Research into marijuana benefits for vets with PTSD in danger of shutdown - Military Times
[The study] has faced numerous problems. Getting federal approval took five years. Officials at Johns Hopkins University in Maryland withdrew from the study shortly after its formal start, leaving [the principal investigator] with a single Arizona site to monitor participants.

California moves to become the first US state to legalise magic mushrooms - International Business Times (U.K.)
Psilocybin is considered a Schedule I drug by the California Controlled Substances Act and the US Drug Enforcement Agency (DEA). Drugs in this ranking have no accepted medical use and a high potential for dependence and abuse, according to the DEA.... However, a New York University study and a Johns Hopkins University research paper published late last year found that psilocybin helped ease anxiety and depression for some cancer patients.

Going deep with psychedelic therapy - Vice
Two years ago, after reading about a study carried out by Johns Hopkins University, which showed that psilocybin had an 80 percent success rate in smoking cessation, I decided to try it out for myself. With ... a handful of freshly picked magic mushrooms, I achieved in an afternoon what years of painful attempts to go cold turkey and abortive nicotine replacement courses had failed to do. I haven't touched – or even thought about – cigarettes since.

VA roadblock hinders study on cannabis as PTSD treatment for veterans, researcher says - The Cannabist (via Denver Post)
The study [to treat post-traumatic stress disorder] moved forward under MAPS [Multidisciplinary Association for Psychedelic Studies], and after receiving funding from Colorado, Johns Hopkins University joined the study in September 2015. However, in March the Baltimore university pulled out of the study without enrolling any veterans.... [A] dispute reportedly arose over federal drug policy, and whether to openly challenge federal rules on medical cannabis research.

Ecstasy could be ‘breakthrough’ therapy for soldiers, others suffering from PTSD - Washington Post
The next step was investigating MDMA’s effects on people. [Rick] Doblin again raised money to fly psychedelic users he had befriended to Stanford University and Johns Hopkins University for spinal taps. The studies were approved by review boards at both institutions.

How to lose weight? Get your brain under control - Boston Globe
“If you have an overweight mother, you’re more likely to become obese,” said Susan Carnell, the study’s author and an assistant professor at Johns Hopkins University’s Department of Psychiatry and Behavioral Sciences. “We were trying to see if there’s something different about the brain in students with a high risk of becoming obese later in life.”

Guns Play Oversize Role in Rural Suicides – New York Times
“Patients with mental health issues should be assessed for gun availability,” said the lead author, Dr. Paul S. Nestadt, a postdoctoral fellow at Johns Hopkins. “We give out condoms and clean needles to people at risk for H.I.V. Why not give out trigger locks to family members of patients at risk for suicide?”
Also covered by Kaiser Health News and Healthline

Montel Williams Shares His MS Treatment Story – WUSA
Features Dr. Adam Kaplin talking about depression in MS.

Researchers leverage PET and MR to uncover serotonin's role in Alzheimer's - Dotmed
“The study shows that the serotonin system is affected in the early stages before memory problems are severe enough to meet criteria for dementia,” Dr. Gwenn Smith, professor and director of geriatric psychiatry and neuropsychiatry at the university, told HCB News. “We hope the study will stimulate development of medications targeting the serotonin system for use in individuals at risk for dementia.”

Scans show lower brain serotonin levels linked to dementia - United Press International
Researchers at Johns Hopkins School of Medicine found that lower levels of serotonin transporter in the brain are linked to dementia. Serotonin transporter is the brain chemical responsible for appetite, sleep and mood.... Researchers examined brain scans of patients with early signs of memory decline and found that lower serotonin transporters may be the driving force of dementia, not a byproduct.
Also reported by: Yahoo News

Humanities in Healthcare - WYPR
How can the humanities be used to help doctors provide better care for their patients? Meg Chisolm, Associate Professor and Vice Chair for Education in the department of Psychiatry and Behavioral Sciences at Johns Hopkins Medicine, spoke about the BEAM (Bedside Education in the Art of Medicine) initiative (@BedEdArtMed).

Weed and depression: Does marijuana make for depressed brains? - U.S. News & World Report
While there is substantive evidence that pot increases the risk of psychotic disorders such as schizophrenia, the link to depression is unclear. “If there is an association, the data are not as robust as with psychotic illness. It’s just conjecture,” says Dr. Eric C. Strain, director of the Center for Substance Abuse Treatment and Research and professor of psychiatry and behavioral sciences at Johns Hopkins.

Psychedelic drugs saved my life. So why aren't they prescribed? - Wired
Roland Griffiths, a professor in the Departments of Psychiatry and Neurosciences at Johns Hopkins University in Maryland, has likened psychedelics' ability to bring about neural rerouting as akin to a "surgical intervention."

When addiction treatment means decades on Methadone – WYPR On Point
…according to Ken Stoller, a psychiatrist at Johns Hopkins Hospital who specializes in addiction psychiatry. For example, he said when Methadone is prescribed properly, there are no real long-term health risks — no more than there might be side effects with any medication. “This is one area of medicine where it seems like there’s more focus on opinion or philosophy as opposed to the science because the science is really, really clear on this,” Stoller said.

'I suffered from an eating disorder you've probably never heard of before' - Women's Health
Several studies ... including one from Johns Hopkins University, have identified [chewing and spitting] as a common behavior in individuals with anorexia, bulimia, and/or other eating disorders, and have suggested it may be a marker of disorder severity.

New Yorker shares tools he’s developed to overcome chronic pain in new book - am New York
[Jim] Curtis defines a “stimulati” as someone who “ignites passion, thought and wellness.” After 20 years seeking out everything from reiki to acupuncture to cryotherapy to treat his pain, he found his own stimulati. They include ... Adam Kaplin, a psychiatrist affiliated with Johns Hopkins Hospital, with whom Curtis created the anxiety-tracking app Mood 24/7, and career coach Denise Spatafora.


As dozens more report blackouts at Mexico resorts, country says it will act on tainted alcohol -Milwaukee Journal Sentinel
Matthew Johnson, an associate professor at Johns Hopkins School of Medicine, has no direct evidence, but the stories [about tainted alcohol] point to several likely possibilities: scopolamine, phencyclidine (better known as PCP) or methaqualone (quaaludes, a drug popular in the 1970s). Based on the many accounts vacationers described, any of those drugs seems to make sense, said Johnson, a specialist in behavioral pharmacology.
Also reported by: USA Today

How to improve your memory and brain health - AARP​
“The GCBH [Global Council on Brain Health] recommends people incorporate cognitively stimulating activities into their lifestyle to help maintain their brain health as they age,” says Marilyn Albert, chair of GBCH and director of the Division of Cognitive Neuroscience at Johns Hopkins University School of Medicine. “The sooner you start, the better because what you do now may make you less susceptible to disease-related brain changes later in life.”

In the context of the opioid crisis, doctors discuss the future of chronic pain treatment - KPCC-FM (Los Angeles)
Against the backdrop of the opioid crisis, we sit down with three doctors to explore the rise of opiates, and how pain treatment can move past them.… Among the guests: Michael Clark, M.D., vice chair for clinical affairs and director of the pain treatment program in the department of psychiatry and behavioral sciences at the Johns Hopkins Hospital.

Psychedelics like shrooms could address depression in a way that's fundamentally different from prescription drugs - Business Insider
[The] shrinking of the sense of self has been linked with long-lasting shifts in perspective — changes that appear to be related to a reduction in symptoms of depression and anxiety. That’s according to clinical trials of magic mushrooms’ active ingredient, psilocybin, in cancer patients at Johns Hopkins and New York University.

Challenging intake guidelines with Dr Graham Redgrave - The Eating Disorder Recovery Podcast 
Tabitha Farrar talks to Dr Graham Redgrave about the research done at Johns Hopkins looking into higher weights and a faster rate of refeeding patients with anorexia in an inpatient hospital setting. 

Are movies about eating disorders fundamentally uncinematic? - Pacific Standard magazine
[Dr. Angela Guarda, director of the Eating Disorders Program at the Johns Hopkins University, says] that filmmakers could emphasize that one recovers from an eating disorder — as most do — through treatment that helps patients create healthy eating habits.... She says that films would do well to also include plots where loved ones encourage a sufferer to get help, providing an audience with practical, helpful information.

Drug testing at raves & festivals could save lives - The Fix
“People would be safest not taking any street drugs at all, but if free, no-fault testing can reduce deaths and other catastrophic consequences, it may be a service worth having,” said Matthew Johnson, associate professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine.

Keith Conners, psychologist who set standard for diagnosing A.D.H.D., dies at 84 - New York Times
The field of child psychiatry was itself still young when Dr. Conners joined the faculty of the Johns Hopkins University School of Medicine in the early 1960s as a clinical psychologist.... Dr. Conners focused on a group of youngsters who were chronically restless, hyperactive and sometimes aggressive.

Clinical trial examines tramadol to treat opioid withdrawal - United Press International
Researchers at Johns Hopkins University have found the drug tramadol, when combined with other therapies, may be effective for treating opioid withdrawal. The results of the clinical trial, published in JAMA Psychiatry, showed tramadol extended-release suppressed withdrawal symptoms more than clonidine and was similar to buprenorphine, both drugs commonly used in opioid withdrawal.
Study also highlighted in NIH Office of Behavioral and Social Science Research website and newsletter.

Can psychoactive drugs help ministers be more effective? University researchers aim to find out - Christian Today
Pastors and priests are taking drugs – but it's all in the name of science. Scientists at Johns Hopkins University in Baltimore have enlisted two dozen religious leaders for a study in which they are given two doses of psilocybin, the active ingredient in 'magic mushrooms'. The idea is to see how a transcendental experience affects religious thinking and whether it makes them more effective in their work, according to The Guardian.
Also reported by: Scientific American

What happens when a rabbi, a priest and twenty two other religious leaders get high on magic mushrooms? - Daily Mail (U.K.)
Religious leaders are taking a psychedelic drug to study its effect on religious experience. Scientists have recruited 24 religious leaders from different faiths and practices to participate in the ongoing study at Johns Hopkins University in Baltimore, Maryland. The participants, who are anonymous, will be given doses of psilocybin, the active ingredient in psychedelic mushrooms.
Also reported by: The Guardian (U.K.)

Surprise: A large share of ‘Molly’ brought to music festivals doesn’t actually contain MDMA, Hopkins researchers say - Baltimore Fishbowl
A medical research team from the school, led by psychiatry and behavioral sciences professor Matthew Johnson, partnered up on a study with the nonprofit DanceSafe, which tested samples of concertgoers’ drugs for free (and without penalty) from July 2010 through July 2015.

The robot sex doll revolution may have some big downsides, experts warn - Vice
There’s no evidence to suggest that these dolls really help anybody, and experts are unconvinced. In fact, Johns Hopkins School of Medicine paraphilia researcher Peter Fagan told the Atlantic in 2016 that childlike sex dolls would likely lead would-be pedophiles to act upon their urges “with greater urgency.”

The fine art of mental illness: What paintings tell us about someone’s psyche - Washington Post and numerous subscribers
James C. Harris, a professor of psychiatry and behavioral science and director of Johns Hopkins University’s Developmental Neuropsychiatry Clinic, spent more than a decade writing monthly essays that connect the visual arts to larger issues of psychiatry and mental illness. Now, those essays and the art that inspired them have been collected by the journal JAMA Psychiatry.

My Time: Lecture combines clinical research with powerful personal narratives - Baltimore Sun
Around 80 people, many of whom are clinical professionals, attended the lecture hosted by Chesapeake Life Center and held May 3 at the Meeting House in Columbia. The first speaker, Dr. D. Andrew Tompkins, an assistant professor in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, shared his research on opioid use disorders and their treatments. Also reported by: Capital Gazette


Here's how much Fitbit users sleep - PC magazine
"These findings further support the general recommendation that most adults need to consistently sleep 7 to 9 hours per night, and illustrate why a good night's rest is so important for your overall well-being," Fitbit advisory panel sleep expert Michael T. Smith, Jr., Ph.D., professor of psychiatry, neurology, and nursing at Johns Hopkins University School of Medicine in Baltimore, said in a statement.

How People With Dementia Can Live at Home Longer – Next Avenue
The MIND program makes a difference, saving money for families and Medicaid
Quincy Samus, an assistant professor at Johns Hopkins who leads the MIND at Home research team, is conducting two more studies of the program. One, through a $6.4 million innovation grant from the Centers for Medicare and Medicaid Services, focuses on low-income older adults and their caregivers. The other, funded with $3.4 million from the National Institute on Aging, looks at participants of all income levels. Both studies will gain insight into the program’s costs and long-term sustainability. Combined, they involve 647 people with dementia and an equal number of family members in central Maryland.

How people with dementia can live at home longer - Forbes
[The Gerben family] got a boost from a program in Maryland called Maximizing Independence (MIND) at Home. [It was] designed in 2006 by dementia specialists at Johns Hopkins University and offered to families as part of Johns Hopkins research that is still ongoing.

 What a ‘transcendent experience’ really means - New York magazine
[O]ne day in 2008, [Janeen Delaney] learned about a study at Johns Hopkins University looking at people facing imminent death. The research team, led by psychiatrist Roland Griffiths, wanted to know whether having a major transcendent experience — induced by psilocybin, the active ingredient in so-called magic mushrooms — would help people like Janeen face death with peace rather than despair.... Janeen signed up.

Alzheimer's patients need special care, but providers aren't ready to give it - Healthcare Dive
Older people with Alzheimer’s have twice as many hospital stays per year as other older Americans…. “People with Alzheimer’s really need a lot of care,” Dr. Kostas Lyketsos, professor of psychiatry and behavioral sciences at Johns Hopkins Medicine, told Healthcare Dive.

9 things to consider when your antidepressant poops out - Everyday Health
Rule out noncompliance. This seems like a no-brainer, but according to Kay Redfield Jamison, Ph.D., a professor at Johns Hopkins School of Medicine, the biggest challenge professionals face in treating bipolar disorder ... is medical adherence. Approximately 40 to 45 percent of bipolar patients do not take their medications as prescribed.

After Mission bust, hemp oil producer to make no-THC products for Kansas - Kansas City Star
Ryan Vandrey, a psychiatry professor at Johns Hopkins University who has studied the effects of cannabis, said it’s hard to pin down how much low-THC hemp oil one would have to consume to have a psychoactive effect. But he said it’s a lot, and most law enforcement agencies haven’t done much to crack down on it, in part because “the hemp law is a little bit confusing.”

Caffeine is a silent performance killer - Huffington Post
New research from Johns Hopkins shows that performance increases due to caffeine intake are the result of caffeine drinkers experiencing a short-term reversal of caffeine withdrawal. By controlling for caffeine use in study participants, Johns Hopkins researchers found that caffeine-related performance improvement is nonexistent without caffeine withdrawal.

The new way to prevent anxiety in kids - Time
Researchers at the University of Connecticut and Johns Hopkins University tested an eight-week therapy for healthy kids who each had at least one parent with an anxiety disorder. During the following year, 31% of kids who didn’t receive the therapy developed an anxiety disorder, whereas only 5% of kids who received treatment developed one.

The VA admits pot could help veterans, but doctors still can't prescribe medical marijuana - Circa
In March, Johns Hopkins University pulled out of a marijuana PTSD study due to a dispute over federal drug policy and whether to challenge federal rules requiring researchers to only use medical cannabis grown by the National Institute on Drug Abuse.

Michael Phelps added to Medibio board of directors - Swimming World
According to a press release put out by Medibio, an evidence-based medical technology company located in Australia, Michael Phelps has been added to the organization’s Board of Directors.... Medibio’s depression diagnostic is being validated in clinical studies undertaken by Johns Hopkins University School of Medicine and The University of Ottawa, among others.


Seniors and depression: Not a normal part of aging - U.S. News & World Report
Dr. Susan W. Lehmann, clinical director of the division of geriatric psychiatry and neuropsychiatry and director of the Geriatric Psychiatry Day Hospital at Johns Hopkins University School of Medicine: “Depression is never considered a normal part of aging,” she says. “While the more of life we live, the more likely we are to experience times of sadness and grief related to loss or change, most people handle these life challenges without developing a persistent depressive disorder.”

The long, hard road to a science of bad drug trips - Motherboard/Vice
[The] renewed interest in psychedelic harm reduction has increasingly attracted individual researchers running psychedelic studies at various research institutions around the world. At the forefront of these psychedelic studies is Johns Hopkins University, which has been pioneering research into the therapeutic potential of psilocybin, the psychoactive component of magic mushrooms, for the last few years.

Alcohol and depression: A risky combination - U.S. News & World Report
[H]aving a mental illness makes treating substance dependence much more difficult. “The dilemma for those with depression is that a drug that produces a transient elevation of mood may make the person think, 'This is helpful,'” says Dr. Eric C. Strain, director of the Center for Substance Abuse Treatment and Research and professor of psychiatry and behavioral sciences at Johns Hopkins University.

Adult ADHD can't be diagnosed with a simple screening test, doctors warn​ (audio) - NPR and numerous subscribers
Dr. David Goodman, an ADHD specialist at Johns Hopkins University and the Adult Attention Deficit Disorder Center of Maryland, [says] that not everyone who experiences the symptoms of ADHD necessarily suffers from the disorder, and that a simple screening test cannot diagnose it.​​

Magic mushrooms might be the "safest" recreational drug, but they're still risky - Mashable
Two recent studies at New York University and Johns Hopkins University found that psilocybin — a key compound in the mushrooms — has promising therapeutic benefits for people with depression. Proponents are seeking to legalize mushrooms for use in controlled, medical settings.

Bipolar disorder dating tips - Teen Vogue
According to Kay Redfield Jamison, Ph.D., a clinical psychologist and professor of psychiatry at the Johns Hopkins University School of Medicine, who both has and studies bipolar illness, the average age of onset is around 22. But some people experience symptoms earlier — right about when they are starting to date.

Magic mushrooms might be the "safest" recreational drug, but they're still risky - Mashable
Two recent studies at New York University and Johns Hopkins University found that psilocybin — a key compound in the mushrooms — has promising therapeutic benefits for people with depression. Proponents are seeking to legalize mushrooms for use in controlled, medical settings.

The truth about 'Blue Whale,' an online game that tells teens to self-harm - Motherboard
Dr. Shannon Barnett, assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, told Motherboard in an email that while this game exemplifies the risk of someone taking advantage of youth who are emotionally distressed, there is no one reason for adolescents to feel so bad that they have suicidal thoughts and/or thoughts of harming themselves.

Bipolar disorder dating tips - Teen Vogue
According to Kay Redfield Jamison, Ph.D., a clinical psychologist and professor of psychiatry at the Johns Hopkins University School of Medicine, who both has and studies bipolar illness, the average age of onset is around 22. But some people experience symptoms earlier — right about when they are starting to date.

Sex workers who use LSD have lower suicide risk, study finds - The Globe and Mail (Canada)
There is a growing body of research into the benefits of psychedelic drugs. In 2014, researchers at Johns Hopkins University in Baltimore reported that some long-time smokers who had failed many attempts to quit did so successfully while receiving magic mushrooms, in the context of a cognitive behavioral therapy treatment program. 

This is how much caffeine it takes to kill an average person - USA Today and numerous affiliates
[T]he limit varies from person to person, says Maggie Sweeney, a postdoctoral research fellow at Johns Hopkins School of Medicine's department of psychiatry. "For adults it would be uncommon to experience effects of caffeine intoxication at less than 250 milligrams of caffeine (or 2.5 cups of coffee)," she said. "...It would typically be more than 12 ounces, but much more common to have the negative effects with greater than 500 milligrams of caffeine."

Psychedelic drugs: The future of mental health - Reason
A recent study found that MDMA-assisted therapy could help veterans suffering from PTSD. Another paper from Johns Hopkins presented evidence that therapy in conjunction with psilocybin mushrooms can help ease the mental suffering of terminal cancer patients. These findings, among others, were presented at the 2017 Psychedelic Science Conference in Oakland, California.

How a man's near-death with cancer inspired him to fund LSD research - Inc.
[E]ntrepreneur Rodrigo Niño has launched Fundamental, a crowdfunding platform that allows people to fund psychedelic research in an effort to develop FDA-approved therapies.... The psychedelic renaissance was jumpstarted by Roland Griffiths, a professor of behavioral biology at Johns Hopkins, in 2006 when he published an influential paper about the meaningful spiritual experiences patients go through while on psilocybin.

Can psychedelic drugs treat mental illness? Scientists need your help to find out. - Huffington Post
This past December ... researchers at [New York University and] Johns Hopkins University published the results of two separate clinical trials on the effects of psilocybin-assisted psychotherapy on patients with cancer-related anxiety and depression. All told, between 60 and 80 percent of the subjects showed clinically significant reductions in both psychological disorders after treatment.

Researchers will soon evaluate risks, benefits of self-medicating with small doses of LSD - Mashable
Two concurrent studies at New York University and Johns Hopkins University found that psilocybin — a key compound in hallucinogenic mushrooms — can help ease existential depression in people with life-threatening cancer, specifically when taken in a controlled setting and combined with therapy.

Is a placebo better than nothing to treat insomnia? - Reuters
Beyond the small number of total participants, another limitation of the current study is that researchers didn’t have objective measurements of sleep quality or duration to compare placebos against no treatment, the authors note in Sleep Medicine. Still, the results make sense because insomnia is ultimately a disorder of perception, said Patrick Finan, a psychiatry and behavior researcher at Johns Hopkins University School of Medicine in Baltimore.

A doorway to change - Psychology Today
At Johns Hopkins, psychiatrist Matthew Johnson led a 2014 pilot study of 15 longtime smokers treated with psilocybin and had found that 80 percent abstained from smoking six months after the trial — an especially compelling result as nicotine dependence is often thought to be primarily physiological....

One family's journey through a mental health crisis - Today
In a Q&A, Dr. Jennifer Payne, a noted researcher and clinician who directs the Women's Mood Disorder Clinic at Johns Hopkins Hospital, tells Today both medicine and society still have a ways to go in the treatment of mental illness.

Can psychedelic drugs treat anxiety and depression? - Men's Health
Psychedelics are again finding favor among scientists. NYU Langone isn't alone: Teams at institutions as varied as Imperial College London, the University of Alabama, and Johns Hopkins are currently studying them.

Know the warning signs of suicide - WBAL-TV
Following a segment on a new Netflix show that focuses on a teenage girl’s suicide, Dr. Holly Wilcox, a professor of psychiatry and behavioral sciences at Johns Hopkins, expresses concern that the show discusses suicide in an irresponsible and graphic way and suggest that if parents want to allow their children to watch it, they should watch it with them.


Psychedelic drugs might actually tap into a higher power (study) - Inverse
“It’s our thought that the foundational underpinnings of the world’s religions may stem from a common sense of unity and interconnectedness, and that perhaps there’s something very similar about them,” says Johns Hopkins psychologist Dr. Roland Griffiths, lead author of the study. 

‘Higher state of consciousness’ from psychedelics is not just a hippie idea — it’s biological - The Fix
As for psilocybin, the active ingredient in magic mushrooms, research from scientists at NYU Langone Medical Center and Johns Hopkins University have found it to be an effective tool for treating depression and anxiety in terminally ill individuals.

What happens if you smoke marijuana every day? - USA Today and numerous subscribers
Dr. Ryan Vandrey, an associate professor at Johns Hopkins Medicine, says you can't generalize marijuana users. Other factors need to be considered, such as their dosage and the reason a person is using the drug. However, he said marijuana can have impact on how people perform at their job or at school. Withdrawal can occur after a period of long-term repeated use.

JCS Partners with Hopkins on Innovative Dementia Study – Baltimore Jewish Times
More than 10 years ago, the late philanthropist LeRoy E. Hoffberger sought to improve the lives of people living at home with dementia and the lives of their caregivers. Together, Hoffberger and Dr. Constantine Lyketsos, director of Johns Hopkins Memory and Alzheimer’s Treatment Center, brainstormed on what became the MIND at Home: Memory Care Coordination studies. (MIND stands for Maximizing Independence)

Howard County's shortage of affordable housing for mentally ill undermines stability* - Baltimore Sun
Demand for Howard County General Hospital's inpatient psychiatric unit is increasing, according to a hospital spokesperson. A new psychiatric unit is part of the plans for a new two-story addition to the hospital, along with a larger expanded emergency unit and a new pediatric emergency unit.

The ayahuasca ceremony is going under the scientific-method microscope - Quartz
[R]ather than playing the sacred songs which are said to influence the effects of the ayahuasca, the researchers are considering using the same recorded music that is used in the psilocybin trials at Johns Hopkins and New York universities. 

Judge sees a boy, not a disorder - Baltimore Sun
One man sees a child suffering from a psychological disorder. The other sees a young civil rights leader. The sharply contrasting opinions of two prominent men from Baltimore – one a former chief psychiatrist at Johns Hopkins Hospital, the other a senior judge of the federal appeals court in Richmond — appear in the case of Gavin Grimm….

The Federal Government Makes It Ridiculously Hard to Study Gun Violence and Medical Marijuana - Scientific American
“It can't come off of Schedule I to a different schedule until the traditional drug development work has been done, and I don't think the traditional drug development work [large phase III trials] really can be done while it's Schedule I,” said Ryan Vandrey of the Johns Hopkins University School of Medicine on February 19 at the AAAS conference. “It's a catch-22.”

New research on treatment for pediatric bipolar disorder focus of UC Davis lecture - UC Davis Health
Robert Findling. Findling is the director of the Division of Child and Adolescent Psychiatry and vice chair in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins. He is also the vice president for Psychiatric Services and Research at the Kennedy Krieger Institute.

The Innovating, Creative Superpowers of ADHD - Yes Magazine
Dr. David Goodman, assistant professor of the Department of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine, explained how a person can have an IQ of 140 or 80 and have ADHD.

5 ways to help a partner who's suffering from mild depression -  Prevention
Instead of reacting negatively to a thought or a feeling about your partner's depression (i.e. "why do you never want to go to the movies?") try asking a question that will make him or her feel like their feelings are valid, suggests Lauren Osborne, MD, assistant director of the Women's Mood Disorders Center at the Johns Hopkins University School of Medicine. Something like, "I notice you have been really irritable and down lately, do you want to talk?"

Hopkins to resume gender reassignment surgeries - Washington Blade
In a little-noticed development, Johns Hopkins Hospital in Baltimore disclosed last July that it would open a new Center for Transgender Health and will resume performing gender reassignment surgeries after a 38-year hiatus.... “We will wait until we are fully staffed and officially open, probably this summer, before we plan any proactive outreach on the new Center for Transgender Health,” [a spokeswoman for] Johns Hopkins Medicine told the Washington Blade in an email.

Can trans people trust Johns Hopkins’s new clinic? - Daily Beast
[I]n a new statement to The Daily Beast ... a Johns Hopkins Medicine spokesperson stated: “Johns Hopkins Medicine has and is taking steps toward becoming an employer and provider of choice for all, including transgender individuals. And statements or actions to the contrary by current or former affiliates of Johns Hopkins do not reflect our institution’s current views. We are committed to being a caring, inclusive place for all patients, families and employees.”

The problem with America's marijuana DUI laws: Science - Reno Gazette Journal
While it would seem logical to model drugged driving laws after existing drunken driving laws, marijuana is a tricky substance. “Alcohol is the exception. Alcohol is the only drug that we can immediately determine whether someone is acutely impaired on the roadside,” said [Dr. Ryan Vandrey, associate professor of behavioral pharmacology research at Johns Hopkins University]. “There are lots of drugs that we don’t have reliable tests for – cannabis is the normative.”


I Saw The Light: Reducing anxiety, stress, depression, more with shrooms – City Paper
Nearly four decades after research into psychedelics was suppressed by the government, a new wave of scientists is restoring legitimacy to a misunderstood and promising area of research. Baltimore is home to arguably the most prestigious psychedelic research program in the world. The studies conducted by Roland Griffiths and his team at Johns Hopkins University School of Medicine did not just commence this new era of legally sanctioned research; they are also the most rigorous scientific studies to date on psilocybin.

Hopkins was ready to test pot as a treatment for PTSD. Then it quit the study. - Washington Post and subscribers
Eighteen months after joining a study on using marijuana to treat post-traumatic stress disorder, Johns Hopkins University has pulled out without enrolling any veterans, the latest setback for the long-awaited research. A Johns Hopkins spokeswoman said the university’s goals were no longer aligned with those of the administrator of the study, the Santa Cruz-based Multidisciplinary Association for Psychedelic Studies (MAPS). Also reported by: The Cannabist, Weed Weekly

Do You Zone Out? Procrastinate? Might Be Adult ADHD - NPR Shots

"It's very important to look at the questions in their totality, not each individual symptom," says Dr. David Goodman, an assistant professor of psychiatry at Johns Hopkins School of Medicine who was not involved in the study. "No single question stands out as indicating ADHD."

Social Media Is Causing Depression Among Teen Girls - MSN
A "steady stream of research" suggests that far more girls than boys are battling major depression in their almost-adult years — and the growing psychological dependence on Snapchat, Facebook, Instagram and other social media may be making young women more vulnerable to mental illness. Ramin Mojtabai’s research is mentioned.

Baltimore's spot in the history of psychotherapy* (audio) WYPR-FM
As the American Association for Psychoanalysis in Clinical Social Work gathered [in Baltimore] this past weekend, [WYPR talked]  to two therapists [including Daniel Buccino, assistant professor in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine and a clinical supervisor in the community psychiatry program at Johns Hopkins Bayview Medical Center] about Baltimore’s special spot in the development of psychoanalysis, the challenges for therapists and residents in a city suffused with trauma….

The sublime psychology of Baltimore - Baltimore Sun
This opinion piece that looks at Baltimore’s "tender and tough, wounded and surviving, swaggering and fearful, Northern and Southern, black and white" psychology was co-written by Daniel Buccino, clinical director of the Mood Disorders Clinic at Johns Hopkins Bayview Medical Center.

Why some women may be more biologically susceptible to postpartum depression - Shape
Researchers estimate that only 15 percent of women who are affected [by postpartum depression] get treatment. That's why we're stoked to see the latest research coming from Johns Hopkins University. It shows that having high levels of an anti-anxiety hormone throughout pregnancy — especially the second trimester — may protect soon-to-be-moms against PPD.

How tripping kills your fear of dying, and why that could change your life - The Rooster
Matthew W. Johnson is a researcher at Johns Hopkins who has the interesting job of giving magic mushrooms to dying people. In one recent study, with FDA approval and university funding, Johnson got 51 cancer patients [high] on mushrooms, and 80 percent of them said it helped them feel more optimistic and less scared of death.

Why the clinical use of psychedelics may heal sexual trauma - Psychology Today
Research on such chemicals as psilocybin (the psychoactive ingredient in "magic mushrooms") and MDMA ("ecstasy") are now in Phase 3 FDA-approved trials, with significant preliminary results. Psilocybin research at Johns Hopkins University and NYU, for example, have found that patients with terminal cancer experienced a reduction in mortality related depression and anxiety and heightened levels of well-being.

Forgiveness … the ultimate freedom - W4CY radio (West Palm Beach, Fla.)
More and more though it is being found that ... feelings [of hurt, anger and resentfulness] negatively impact our health: “There is an enormous physical burden to being hurt and disappointed,” says Karen Swartz, M.D., director of the Mood Disorders Adult Consultation Clinic at The Johns Hopkins Hospital. "Forgiveness, however, calms stress levels, leading to improved health.”

The psychedelic miracle - Rolling Stone
Currently – legally – we're in the midst of a psychedelic renaissance. New York University, the University of New Mexico, the University of Zurich, Johns Hopkins University, the University of Alabama and the University of California-Los Angeles have all partnered with the psilocybin-focused Heffter Research Institute, studying the compound for smoking cessation, alcoholism, terminal-cancer anxiety and cocaine dependence....


Hope you’re ready for the next episode - Boulder Weekly (Colorado)
[P] is getting attention for proving very (very) effective in treating notoriously difficult to treat conditions like end-of-life anxiety, chronic depression and addiction. As just one example, in a 2016 study performed by Johns Hopkins University School of Medicine ... it was reported that 80 percent of patients showed “large decreases in clinician and self-rated measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety.” Six months later the results were sustained without further treatment.  

Could a club drug be the secret to curing PTSD? - Elle
Other psychedelics [besides MDMA] are also yielding promising lab results, including psilocybin (the active ingredient in so-called magic mushrooms), which teams of researchers from Johns Hopkins and New York University found can reduce anxiety and depression in cancer patients.

'River on Fire' explores genius, madness and the poetry of Robert Lowell - NPR and numerous affiliates
Kay Redfield Jamison's new book describes how Lowell's manic-depressive illness influenced his life and work. "His manias tended to lead him into writing a fresh kind of poetry," she says.... She's a professor in mood disorders and psychiatry at the Johns Hopkins University School of Medicine.

Senior Nation: The Science of Forgetfulness with Dr. Constantine Lyketsos (video)
Chestertown Spy (Eastern Shore)
On March 8, the Talbot Hospice will be sponsoring a lecture by one of the leading experts in dementia and Alzheimer’s disease at Easton High School. Dr. Lyketsos, from the [Johns] Hopkins department of psychiatry and behavioral sciences, will address these issues and the devastating effects of the illness, but also promising new treatments. The Spy traveled to Baltimore to sit down with Lyketsos before the event for a primer on dementia and memory loss.

Why having sex on cocaine can be dangerous - Esquire
Cocaine makes people do risky [stuff], and science has long tracked the increased risk of cocaine users contracting STIs. But the reason was never scientifically clear. A new, government-funded (!) study from Johns Hopkins, however, found that cocaine use not only increases sexual desire, but it makes that sex more dangerous. 

Can all suicides be prevented in an inpatient facility like St. Joe's?CBC (Canada)
Dr. Geetha Jayaram is quoted.

Kay Redfield Jamison puts Robert Lowell on the couch in a fascinating biography - Washington Post
Jamison contends that “instability and the relentless recurrence of [Lowell's] illness hardened his discipline while mania impelled and stamped his work.” To establish her diagnosis, this distinguished professor of psychiatry at the Johns Hopkins School of Medicine and author of the best-selling memoir “An Unquiet Mind” brings to bear everything she can think of.

The Rise of Mood Tracking: How Big Data Can Transform Psychiatry – Reach MD
Dr. Adam Kaplin, founder and inventor of Mood 24/7, discusses the emergence of mood tracking portals and how they can transform mental health care.

Worrying about your grown kids really can keep you up at night - Reuters
[S]ome parents who worry excessively about their adult children might benefit from therapy to improve coping skills or minimize stress, said Dr. Patrick Finan, a researcher in psychiatry and behavioral health at Johns Hopkins University School of Medicine in Baltimore who wasn't involved in the study.

Marijuana as medicine? Weed study exploring clinical trials on military veterans with post traumatic stress disorder - International Business Times
Participants will finish 17 outpatient visits to one of the two study location clinics — one in Phoenix, led by Dr. Sue Sisley, and another at Johns Hopkins University in Baltimore, led by Ryan Vandrey. The team will be tracking measurements of PTSD, PTSD symptoms and safety data to dig for “vital information on marijuana dosing, composition, side effects, and areas of benefit to clinicians and legislators considering marijuana as a potential treatment for PTSD. ”

Cocaine users are more likely to have sexually transmitted diseases – for this reason
The Telegraph (U.K.)
People who regularly use cocaine are more likely to have sexually transmitted diseases than non-users. According to a new study by researchers at the Johns Hopkins University School of Medicine, this may in part be due to a "sexual-impatience" brought on by the drug which increases the likelihood that users will not bother to use condoms. Also reported by: Inverse, Med India

Can LSD treat depression? Microdosing in the mainstream - WTOP-AM
When routine therapies and medications failed to help Ayelet Waldman overcome intense mood swings and a deep depression, she turned to something that is generally associated with harm, not health: LSD. Waldman heard about microdosing, or taking tiny doses of drugs, thanks to its growing presence in the media. Researchers at Johns Hopkins and New York universities have studied the impact of psychedelic drugs on cancer patients for anxiety.

Marijuana anxiety? Here's what to do if you have a panic attack while high - Mic
Can weed cause panic attacks? "It can," said Ryan Vandrey, who studies the behavioral pharmacology of cannabis use at Johns Hopkins University School of Medicine, in a phone interview. "It happens from direct effects of the drug in the brain and/or direct effects of the drug on body."


The potentially dangerous effect cocaine can have on your sex life
A study by the Johns Hopkins University School of Medicine in Baltimore, United States has discovered a correlation between people who use cocaine and the increased risk of catching and spreading STIs.

Is the Mediterranean diet good for kids, too?
For parents who would like to introduce a Mediterranean diet into their children's daily eating routine, Dr. Carolina Vidal, an assistant professor of psychiatry and behavioral sciences at Johns Hopkins Medicine, offered a few tips. "Slowly introduce fruits and vegetables, and present them consistently with the other foods they eat.

(Yes, it’s possible to have too much caffeine (and these are the caffeine overdose symptoms to look for)
Life-threatening incidents of caffeine overdose are fortunately extremely rare, says Maggie Sweeney, PhD, a postdoctoral research fellow at the Johns Hopkins University School of Medicine who studies caffeine. "It would be very difficult to get to a lethal dose of caffeine through consuming coffee," she explains. "[Coffee] sort of has preventive measures because it is difficult to consume that volume of liquid."

Treatment can help turn around opioid abuse (video)
"I used Percocet for four or five years. When that became too expensive, I switched to heroin," [Ashley] Stuart said. "I lost my storage, my car, my house and my job." With that loss, Stuart sought help at the Johns Hopkins Broadway Center for Addiction, where she goes for buprenorphine treatments and gets extensive counseling. The center's director, Dr. Kenneth Stoller, said treatment is what this opioid epidemic needs.

FDA clears Lurasidone (Latuda) for schizophrenia in adolescents* (study)
"The impact on development and poor prognosis frequently associated with schizophrenia that begins in adolescence underscores the need for treatment that is both well-tolerated and effective," Robert Findling, MD, vice president, psychiatric services and research, Kennedy Krieger Institute, and director of child and adolescent psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, and a study investigator, said in the release. "The availability of Latuda provides healthcare providers with an important new option for helping adolescents with this illness…." added Dr Findling.

Hit the hay: Three reasons why good sleep is crucial for mental health
Psych Central
One in three American adults don’t get enough sleep. Though Johns Hopkins Medicine reports that as many as ninety percent of North Americans respond to this chronic lack of sleep with a regular dose of caffeine, that little pick-me-up doesn’t cut it.

Magic mushrooms as mental health treatment
U.S. News & World Report
[Sherry] Marcy learned about an ongoing study at Johns Hopkins University using psilocybin for cancer patients with persistent, treatment-resistant depression. Marcy, who had never tried psychedelic drugs recreationally – she didn't disapprove; it just wasn't her thing – experienced her first drug trip as a study volunteer.

Hallucinogens: Future of mental health treatment?
Matthew Johnson, PhD, a research psychologist at Johns Hopkins University, says he’d be surprised if hallucinogenic drugs didn’t have a proper medical use “under some constrained, limited circumstances.” “Most powerful substances that we know of, that have powerful effects on the central nervous system, are like any powerful tool,” says Johnson, who has studied how psilocybin affects depression. “They can have dangerous effects, or beneficial effects...."

I didn’t believe I had an eating disorder. But the threat of forced feeding saved my life
“Those of us who have treated 1,000 plus patients know that we are bad at predicting who will recover and have seen recovery in some of the most severely ill and chronic cases, even in cases who failed multiple treatments,” [Angela Guarda, director of the eating disorders program at Johns Hopkins University] said in an email. “There is much danger in viewing anorexia as a terminal illness. Instilling hope and helping patients find a path to recovery should always be our goal.”

Why psychedelics like magic mushrooms kill the ego and fundamentally transform the brain
Business Insider
On a chilly December morning, [Clark] Martin walked into the facility at Johns Hopkins, where he was greeted by two researchers, including Bill Richards, a psychologist. The three of them [went] over the details of [a] study and what might happen. Martin received a pill and swallowed it with a glass of water. For study purposes, he couldn't know whether it was a placebo or psilocybin, the drug the researchers aimed to study.

How LSD saved one woman’s marriage
New York Times
Researchers at institutions like New York University and Johns Hopkins have yielded promising results administering psilocybin to cancer patients to relieve anxiety, combat obsessive-compulsive disorder and even treat addiction to other drugs.

Researchers are giving religious leaders hallucinogenic drugs to understand mystical experiences
Business Insider
In recent weeks we've heard more and more about the resurgence in psychedelic research, with scientists from Johns Hopkins and New York University talking about how hallucinogenic psilocybin could work "like a surgical intervention for mental illness."

Religious leaders are experimenting with psychedelics for scientific purposes
The indescribable high, intense emotions, and intimate sense of self experienced under the influence of magic mushrooms are similar to another kind of trip: a religiously mystical experience. So, as science naturally muses, let's give shrooms to deeply religious people and see what happens. That's how [13 religious leaders] started taking psilocybin, the active ingredient in magic mushrooms, at Johns Hopkins University and New York University.

LSD, yoga, and the therapeutic process of ‘ego dissolution’
New York magazine
A Johns Hopkins study last year found that psilocybin helped people who had been smoking a pack a day for decades quit at double the success rate of the best pharmaceutical treatments. “Our data does indicate that stronger mystical experiences are associated with success,” lead author Matthew Johnson told Science of Us.

Researchers are feeding priests psychedelic drugs in the interest of science
[R]esearchers have found consistent overlap between mystical experiences that occur naturally and those that are caused by psilocybin. “All we’re doing is finding conditions that increase the likelihood of these mystical experiences, and we still don’t know their ultimate cause,” says Roland Griffiths, a principal investigator across multiple Johns Hopkins psilocybin trials.



Some sobering info about bad shroom trips amidst the psychedelic renaissance
In a recent survey of nearly 2000 people, a group of psilocybin … researchers at Johns Hopkins University looked at anecdotally reported "bad trips" to understand the enduring positive and negative consequences of a drug gone wrong. A majority of those surveyed said that the difficult shroom trip was among the ten biggest challenges they've ever faced, but also among the most "meaningful" or "worthwhile" experiences of their life.

Treatment with magic mushrooms should be done with caution, researchers say
Baltimore Sun
“Considering both the negative effects and the positive outcomes that [survey] respondents sometimes reported, the survey results confirm our view that neither users nor researchers can be cavalier about the risks associated with psilocybin,” Roland Griffiths, a psychopharmacologist and professor of psychiatry and behavioral sciences and neurosciences at the Johns Hopkins University School of Medicine, said in a statement.

The global experiment of marijuana legalization
"We need a lot more data to inform the policies that are happening," said Ryan Vandrey, associate professor of behavioral pharmacology at Johns Hopkins University…. He has no stance on whether marijuana is "good or bad," he said, but wishes policies around the drug had the data typically required when approving a new therapy.

Carrie Fisher was a 'bright light' for people struggling with bipolar disorder
When someone like Carrie Fisher speaks about their experiences with a mental illness, “it demystifies it,” said Dr. Dean MacKinnon, an associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine.... “It can make it a lot less frightening to go to see a psychiatrist for the first time,” MacKinnon added.

Cannabis company Charlotte’s Web aims to protect the brain with hemp oil
LA Weekly
The Realm of Caring, whose mission is to educate the general public and policy makers to the benefits of cannabinoid supplements and performing advocacy for those using cannabinoid therapies … collaborates with Johns Hopkins University School of Medicine to help validate the benefits of cannabinoid therapy

Gift of the fungi: Mushrooms — yes, mushrooms — could help save the world
Earlier this month, mushrooms momentarily sprouted into the news when two studies from Johns Hopkins and New York University found that a single magic mushroom trip (a mushroom with the naturally occurring psychedelic ingredient psilocybin) produced immediate, substantial and prolonged improvements in the levels of anxiety, depression and hopelessness for cancer-stricken patients.

Are psychedelics the new Prozac?
Outside Magazine
Scientists at the Johns Hopkins School of Medicine, led by professor of psychiatry and neuroscience Roland Griffiths, have used moderately high doses of psilocybin to arrest major depression and existential anxiety among terminal cancer patients.

Illegal drugs that are now used as medicine (study)
“It’s not the drugs themselves that are producing all these therapeutic benefits. It’s usually the drug experience in combination with supportive psychotherapy,” study author Albert Garcia-Romeu, Ph.D., a psychiatrist at Johns Hopkins University, told Healthline.

Understanding brain chemistry important to breaking addiction, experts say
Dr. Kenneth Stoller, the director of the Johns Hopkins Broadway Center for Addiction, said the drugs are so powerful that they overwhelm a system not used to massive amounts of opioids, and it starts to change.

NFL might be warming to idea of studying potential medicinal benefits of marijuana
Orange County Register
Ryan Vandrey is still skeptical of what [a study of current players] may find. A Johns Hopkins associate professor who helped craft the study, Vandrey cautions that its results won’t definitively prove marijuana’s effectiveness in treating pain, but could be a vital “starting point.”

Psilocybin, LSD, and the inner life
Psychology Today
Regardless of the risk-benefit analysis of using powerful psychotropic substances to treat mood and substance use disorders, [recent] NYU and Johns Hopkins studies point to something else of note: the relationship between psychological well-being during times of crisis and some sort of mystical/contemplative practice.

Wilmington police struggling with repeated overdose patients
Star News (Wilmington, N.C.)
Reversing an overdose could represent the turning point in someone's addiction, but they must already be prepared to seek treatment, said Dr. Kelly Dunn, a psychiatric and behavioral sciences professor at Johns Hopkins University.

Drug policy experts and advocates implore DEA to keep opiate-like plant legal
Washington Post
[Johns Hopkins addiction specialist Jack] Henningfield, working with the drug policy consulting group Pinney Associates, produced a 127-page analysis that concludes that placing kratom under the DEA's jurisdiction as part of the Controlled Substances Act "is not warranted from a public health perspective and is more likely to cause public health problems that do not presently exist."

'I saw my fear': How psychedelic therapy is making a comeback (study)
Roland Griffiths, a psychiatry professor who led the psilocybin trial at Johns Hopkins, said he started studying the compound because he was deeply curious about its conscience-expanding properties. The Johns Hopkins team ... focused their [new] research on cancer patients suffering from crushing existential anxiety.
Also reported by: redOrbit, Nature World News, Science World Report, Argyll Free Press (Scotland), PBS, Smithsonian, Canada Journal, Jewish Business News

There's something in magic mushrooms that's shown to ease anxiety and depression in cancer patients in one dose (studies)
Los Angeles Times
Johns Hopkins University psychiatrist Dr. Roland R. Griffiths, the lead author of one of the two studies, said the enduring relief provided by a single dose of psilocybin makes such treatment more akin to surgery than it does to the plodding, labor-intensive treatments that remain the mainstay of his profession.
Also reported by: NBC News and numerous subscribers, CBS Evening NewsVoice of America, Time, Bloomberg, Huffington Post, New York magazine, Popular Science, Live Scientist, New Scientist, mic, Reason, Gizmodo, Yahoo, Daily Times (Pakistan), The Guardian (U.K.), Business Insider, PBS Newshour, Crain’s New York Business, Newsmax, Quartz


Three cancer patients explain how a psychedelic drug eased their fears
Washington Post
New research finds that psilocybin, the long-banned active compound in “magic mushrooms,” helps cancer patients deal with the anxiety, depression and fear of death that often accompanies the disease. [The three patients took part in] clinical trials at Johns Hopkins University School of Medicine and New York University Langone Medical Center. (See above listing.)

Psychedelics reduce anxiety, depression in patients, study finds
Baltimore Sun
Researchers at the Johns Hopkins University School of Medicine have found that a psychedelic drug can significantly reduce anxiety, depression and other emotional distress in cancer patients. The patients experienced almost immediate relief, which lasted for months, after taking psilocybin, the active hallucinogenic ingredient in "magic mushrooms," the researchers reported. Also reported by: New York Times, Washington Post, The Atlantic, CNN, Associated Press and numerous subscribers, The Verge, Stat, Newsweek, Scientific American, USA Today, Vice

Johns Hopkins study finds evidence of brain injury in young NFL players (video)
A year-long study at Johns Hopkins found evidence of brain injury in young or recently retired NFL players. Researchers said they have found evidence of brain injury and repair that is visible on imaging from the players, compared to a control group of men without a history of concussion.

Tests may help spot brain damage after even mild concussions (study)
Reuters and numerous subscribers
“The study showed that there is a measurable degree of this biomarker of brain injury and repair even in young NFL players, suggesting that the insult to their brains could have occurred long before they were scanned for the study — perhaps dating to collegiate or pre-collegiate play,” said senior study author Dr. Martin Pomper, a researcher at Johns Hopkins medical school in Baltimore.
Also reported by: Baltimore Fishbowl

The battle over involuntary psychiatric care (audio)
The Diane Rehm Show
Dinah Miller, an instructor in psychiatry, and Annette Hanson, an assistant professor of psychiatry, both at Johns Hopkins University School of Medicine, are among the guests talking about how patients can be helped and traumatized by involuntary psychiatric care.

Could marijuana compound CBD help NFL players with pain? (video)
CBS News
Ryan Vandrey studies the effects of marijuana at Johns Hopkins University.... He’s collecting surveys from current [NFL] players to see how the athletes deal with pain. Vandrey said we still have a lot to learn about the long-term impact of medical cannabis. “It may be beneficial for a number of these health conditions, but it may also be harmful,” Vandrey said.

Kratom: The bitter plant that could help opioid addicts — if the DEA doesn’t ban it
“The two main alkaloids in kratom, mitragynine and 7-hydroxy, appear to have a low ceiling for respiratory depression,” says pharmacologist Jack Henningfield of the Johns Hopkins School of Medicine. “And that’s why if you look hard, it’s very difficult to find deaths attributable purely to kratom.”

I don't like my partner smoking pot. What should I do?
Chicago Tribune
[B]e open and forward about it, says Dr. Ryan Vandrey, associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, who studies the effects of cannabis use. Indicate whether you would like to see abstinence moving forward or a reduction in use to a certain frequency — once a month or less, for instance.

Can Medication Stop Opioid Epidemic?
On the Record with Sheila Kast
Local NPR affiliate, WYPR devoted two days this week to medication assisted treatment for opioid use disorder. The second part, which aired 11/15/16, was an interview with Ken Stoller, Director of the 911 Broadway Addiction Treatment program at the Johns Hopkins Hospital.

78 people die a day from opioid overdose, surgeon general says in landmark report 
NBC News
"[The 1964 surgeon general's landmark report on the dangers of smoking] really helped to focus us as a culture and as a medical profession," Dr. Eric Strain, director of the Center for Substance Abuse Treatment and Research at the Johns Hopkins University School of Medicine, told NBC News. "This is a report that likewise hopefully will galvanize us to say, 'Hey, these are conditions that are medical problems, we have a database and approaches that can help. It's not hopeless and we can make a difference in the lives of people.’ ”

Beware Bogus Theories of Sexual Orientation
Scientific American  
A new battle over sexual orientation

Women with schizophrenia share the hardest thing about their illness
Though there's no "cure" for schizophrenia, with proper care, it can be treated. "Unlike what many think, schizophrenia is not a hopeless condition that dooms those with the condition to a life of tormenting, homelessness, and violence," Russell L. Margolis, M.D., Clinical Director, Johns Hopkins Schizophrenia Center, told Revelist.

Can Medication Stop the Opioid Epidemic? (audio)
Tens of thousands of Marylanders - of all ages, in all parts of the state - have a drug problem. Every time they use, they’re in danger of overdosing. The number of deaths in Maryland related to heroin tripled between 2010 and 2015. Yesterday we heard a young woman’s story of heroin addiction and recovery using methadone. Today we hear from Dr. Kenneth Stoller, director of the Johns Hopkins Broadway Center for Addiction, which provides outpatient drug treatment services. He explains how medication-assisted treatment works and why increased access would be a public health benefit. Can medication-assisted treatment stop the opioid epidemic?

The Existential Medicine
Baltimore Magazine – November 2016
Decades after psychedelic drugs were outlawed, Johns Hopkins trials are revealing their dramatic therapeutic potential. Features Roland Griffith’s psilocybin research.

Forgiving is good for you
Psychology Today Blog – Nov 3
Forgiveness is a kind of protection…“There is an enormous physical burden to being hurt and disappointed,” says Karen Swartz, M.D., director of the Mood Disorders Adult Consultation Clinic at The Johns Hopkins Hospital. Chronic anger affects your heart rate, blood pressure and immune response.

The surprising link between loneliness and Alzheimer's (study)
Health – Nov 2, 2016
In an editorial published along with the study, Paul B. Rosenberg, MD, associate professor of psychiatry and behavioral sciences at Johns Hopkins Bayview Medical Center, called the findings “important and intriguing.” Doctors are always looking for new and effective ways to screen patients in the early stages of dementia, he writes.


How ‘Shock Therapy’ Is Saving Some Children With Autism
The Atlantic – Oct 27, 2016
Electroconvulsive therapy is far more beneficial—and banal—than its torturous reputation suggests.
Features the story of a patient treated by Dr. Irving Reti and his ECT team.

How ‘shock therapy’ is saving some children with autism
Given its reputation, the most shocking thing about electroconvulsive therapy might be how beneficial — and banal — it actually is. Features the work of Dr. Irving Reti, Director of the Brain Stimulation Program.

Johns Hopkins testing drug that could prevent Alzheimer's disease (Video)
Johns Hopkins is one of 67 international medical centers taking part in groundbreaking research on Alzheimer's disease. The 'Anti-Amyloid in Asymptomatic Alzheimer's', or A4 Study , could be a game changer for the millions of people who have the condition, taking aim at Alzheimer’s before memory ever slips.

Mushroom City Arts Festival returns to Leakin Park
Baltimore Fishbowl
Talks in the tent [tackled] topics such as mushrooms and permaculture, mushroom water colors, mushroom tea and even the magic side of mushrooms with talks on their psychedelic effects. Johns Hopkins is renowned for its psilocybin research.

The heated battle over when to commit a patient involuntarily to psychiatric care (Opinion) Washington Post
problem arises ... when people deemed mentally ill do not want treatment, and society must decide whether to force it upon them. That tension is the subject of “Committed: The Battle Over Involuntary Psychiatric Care” by Dinah Miller and Annette Hanson, two psychiatrists affiliated with the Johns Hopkins School of Medicine.

Hurting the seriously ill rather than helping
(Opinion) Washington Times
Dr. Paul McHugh of Johns Hopkins Hospital is quoted in this piece on a vote by the D.C. Council this week to add a physician-assisted suicide bill to its legislative agenda.

Dr.Thomas Lynch, psychiatrist and psychoanalyst, dies.... Dr. Thomas Lynch, a retired psychiatrist and psychoanalyst who taught at the Johns Hopkins University School of Medicine, died Tuesday of complications from Parkinson's disease at his Charlesbrook home. He was 94.—Baltimore Sun*

Behavior therapy linked to less stress from insomnia.... While the findings don’t suggest doctors should stop prescribing sleep aids, the results do help to make a case for physicians to consider cognitive behavioral therapy as a good first option for some patients, said Patrick Finan, a researcher at Johns Hopkins University School of Medicine in Baltimore who wasn’t involved in the study.—Reuters and numerous subscribers

(Opinion) Authors defend controversial report on sexuality…. Dr. Paul R. McHugh, University Distinguished Service Professor of Psychiatry and a professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, and Dr. Lawrence S. Mayer, a scholar in residence in the Department of Psychiatry at the Johns Hopkins University School of Medicine, take issue with critics of a paper they wrote titled “Sexuality and Gender.”—Baltimore Sun*

Leave No Stone Unturned by Krista Baker, LCPC (Early Psychosis Intervention Clinic, JH Bayview) One therapist’s mission to grow specialized, community-based mental health care that everyone can access-- Partners for Strong Minds Blog

Brain game claims fail a big scientific test.... George Rebok, a psychologist at Johns Hopkins University who has been involved in brain training research for the past 20 years.... [and] who says he has no ties to brain training companies, remains optimistic that the right program of brain exercises can improve mental functioning and delay the effects of aging.—NPR and numerous subscribers

NIH issues report on optimizing youth suicide prevention efforts.... In an accompanying evidence review, researchers called for suicide prevention data to be linked to current data systems. Holly C. Wilcox, PhD, from the department of psychiatry and behavioral sciences at Johns Hopkins School of Medicine, and colleagues noted that their association represents "untapped potential to evaluate and enhance suicide prevention efforts."—Healio

(Opinion) Hopkins faculty disavow 'troubling' report on gender and sexuality…. Respect is the cornerstone of university life: respect for speech and a diversity of views; respect for students, colleagues and patients; and respect for science, which is our lifeblood as an institution. As faculty at Johns Hopkins, a major educational, research and health institution, we are writing to express our concern about a recently published report that we believe mischaracterizes the … state of the science on sexuality and gender.—Baltimore Sun

Children with Tourette syndrome may have an edge at language…. Researchers from Newcastle University, Johns Hopkins, and Georgetown University link the abnormalities associated with TS with a faster ability to assemble sounds into words in a study published in the latest edition of the Brain and Language Journal.—United Press International

Dealing with painful reality of pain management.... To Dr. Michael Clark, [a] multimodal approach to pain has a back-to-the-future quality. Clark, the director of the Chronic Pain Treatment Program at the Johns Hopkins Hospital in Baltimore, runs what he calls one of the last remaining in-patient, interdisciplinary chronic-pain programs, in place since the 1970s.—Houston Chronicle

(Commentary) Psychedelic experiences could "cure" smoking and OCD. Should we allow them? … Studies involving psychedelic drugs by Johns Hopkins researchers Roland Griffiths and Matthew Johnson are mentioned in this article.—Vox


Human Rights Campaign sets sights on Johns Hopkins after controversial trans report…. The movement's latest effort is a controversial 143-page report that LGBTQ advocates consider an early Christmas gift to religious conservatives. Its authors are Dr. Paul McHugh and Dr. Lawrence Mayer of Johns Hopkins University's Bloomberg School of Public Health and School of Medicine.—NBC News

(Video) Johns Hopkins researchers using psychedelic to help longtime smokers quit.... Smokers struggle their entire lives with quitting, but some researchers at Johns Hopkins believe there's a much easier way to do it. [Their] new study involves a combination of talk therapy and the use of psilocybin, a chemical found in magic mushrooms.—WMAR-TV

How backyard pot farming is helping kids with autism.... “I worry a lot about a physician sending a child, or a child’s parents, to a dispensary to have a conversation about what type and dose and route of administration of cannabis should be given to a kid,” says Ryan Vandrey, associate professor of behavioral sciences at Johns Hopkins University in Baltimore. “To me, that’s completely backwards,” he says. Vandrey studies the effects of marijuana exposure on adults.—The Atlantic

Why do we use shock therapy? ... “When it was first developed, it was administered without anesthesia,” says Irving Reti, an associate professor in the departments of psychiatry and neuroscience and director of the Electroconvulsive Therapy (ECT) Service at Johns Hopkins Hospital in Maryland. “[ECT] caused seizures with a lot of motor activity, and people had a higher rate of joint dislocations and fractures. It was an unpleasant treatment.”—Science Friday

Are you getting too much caffeine? ... While everyone's tolerance is different, getting more than your normal amount could make you feel nervous, anxious, irritable, jittery, and could cause excessive urine production or irregular heartbeat, says caffeine researcher Maggie Sweeney, Ph.D., postdoctoral research fellow at the behavioral pharmacology research unit at Johns Hopkins University School of Medicine.—Consumer Reports

Keep your brain young by staying fit.... [A]erobic exercise creates higher levels of a protein known as brain-derived neurotrophic factor, or BDNF, which helps repair and protect the brain, explains Marilyn Albert, director of the division of cognitive neuroscience at Johns Hopkins Hospital in Baltimore.—AARP Bulletin

Coffee 80 times stronger than espresso could keep you up for 18 hours....�People with pre-existing heart conditions, as well as children and pregnant women, are advised to drink less caffeine — but how much is too much varies significantly from person to person, according to Maggie Sweeney, a Johns Hopkins University researcher who studies caffeine. "That's certainly an awful lot of caffeine," Sweeney said of the [Australian]�brew's 5 grams.—CNN and numerous subscribers

5 reasons you can’t get turned on anymore.... [I]t’s very normal for women to experience problems with sexual desire at some point, Kate Thomas, Ph.D., a director of clinical services in the sexual behaviors consultation unit at the Johns Hopkins Hospital, tells Self.—Self


Adolescent depression…. Join host Prentiss Pemberton and his guest, national expert Dr. Francis Mondimore, from Johns Hopkins University School of Medicine, as they discuss the signs, symptoms, and treatment of adolescent depression.—KSKA-FM(Anchorage, Alaska)

Growing research finds psychedelics effective in treating disease…Last year, Johns Hopkins completed a study of individuals suffering from a life-threatening cancer diagnosis. The patients were administered psilocybin for end-of-life anxiety and depression symptoms. - Baltimore Sun

What amnesia tells us about memory … What happens to your sense of self when your memory is gone? What can amnesia teach us about memory? Dr. Jason Brandt, a neuropsychologist at Johns Hopkins School of Medicine who specializes in memory and memory disorders, joins us in studio to explore these questions.—WYPR-FM

Doctors in Md., US struggle with medical marijuana knowledge gap.... “At this point with where we are in the regulatory space, with half the U.S. offering medical use of marijuana, we can’t pretend that it’s not happening,” said Ryan Vandrey, an experiment psychologist at the Johns Hopkins University School of Medicine whose research focuses on the behavioral pharmacology of cannabis.—Maryland Daily Record*

Parents can help children cope with back-to-school anxiety…. Johns Hopkins Medicine child psychologist Dr. Elizabeth Reynolds said back-to-school anxiety is common and can even impact kids who love school….. "Symptoms of anxiety in children include stomach aches, headaches, difficulty falling asleep or staying asleep at night, children wanting more parent time at night," Reynolds said.—WBAL-TV

Losing or keeping your cool: The science of why we sweat​...."I do think there's a cultural stereotype, there. When we see someone sweating, it means they are losing their cool--literally," said Carisa Perry-Parrish, a psychologist who cares for patients at the Center for Sweat Disorders at Johns Hopkins Medicine in Baltimore.—Newsworks

ICU stays are linked to depression in Johns Hopkins Study…. Nearly one in three patients released from the Intensive Care Unit could be diagnosed with clinical depression, a new Johns Hopkins study suggests. The Hopkins researchers analyzed studies dating from 1970 to 2015 that all together tracked more than 4,000 people after they left the ICU. Nearly one third of them had symptoms of persistent clinical depression within one month to one year after their discharge.—Baltimore Fishbowl

Depression common after time spent in ICU…."It's very clear that ICU survivors have physical, cognitive and psychological problems that greatly impair their reintegration into society, return to work and being able to take on previous roles in life," said study senior author Dr. Dale Needham, professor of medicine at Johns Hopkins University School of Medicine in Baltimore.—U.S. News & World Report

Is it true that marijuana hasn't caused any deaths, while prescription drugs have caused 100,000?.... Dr. Ryan Vandrey, a researcher at Johns Hopkins University who specializes in the behavioral effects of marijuana, stressed that looking only at deaths from direct overdoses is a narrow way of examining a drug’s health effects.—Politifact

New medical marijuana policy is a catch-22, researchers say.... Marijuana's legal status as a "Schedule I" drug, which makes it an illegal drug on the federal level, "severely constrains the access and the number and type of people who can do research with cannabis," said Ryan Vandrey, an associate professor of psychiatry and behavioral sciences at The Johns Hopkins University School of Medicine who studies marijuana.—LiveScience

What marijuana researchers think about the DEA ruling…. “It’s not going to affect it much,” Johns Hopkins medical school psychiatrist Ryan Vandrey, Ph.D., a researcher studying the effects of marijuana on people with PTSD, told Inverse. While he admits that increasing access to the drug will be helpful … the DEA’s ruling skirts the real issue marijuana researchers face. “What this didn’t address is the mountain of regulatory hurdles we have to surmount in order to do our studies,” says Vandrey.—Inverse

How to fight chronic pain with more than opioids....Johns Hopkins Hospital in Baltimore has [an] ...inpatient program that helps patients taper off high doses of opioids while receiving other treatments. It attracts people who have suffered from pain an average of 11 years, said Michael Clark, a psychiatrist who directs the program.—Philadelphia Inquirer

Shedding light on the dark field.... Before [Wayne Bowers’] second jail term he joined a programme for sex offenders at the Johns Hopkins sexual disorders clinic in Baltimore. The anti-androgens they prescribed helped, he says: “I still knew the attraction, but didn’t feel aroused.”—The Economist (U.K.)

More US teens may be facing depression: Here's why.... [P]art of being a teen is learning independence and autonomy, said Dr. Leslie Miller, a professor of child and adolescent psychiatry at Johns Hopkins University School of Medicine in Baltimore. If a teen is feeling bad due to depression, he or she may miss out on important milestones, she said.—LiveScience

SAMHSA creates new CMO position in medicine-based restructuring.... Anita Smith Everett, M.D., an associate professor of psychiatry at Johns Hopkins is a newly named chief medical officer of the federal government's Substance Abuse and Mental Health Services Administration…. As the administrator of a community health center at Johns Hopkins, she has extensive experience with clinical treatment and program administration.—Alcoholism & Drug Abuse Weekly

Sex assault survivor who blew whistle denied accommodation by Va. IG.... Managing [Cathy] Hill’s needs was “not a problem,” said Dr. Anita Smith Everett, a former supervisor of Hill’s and Virginia’s first inspector general for behavioral health. “PTSD is somewhat unpredictable, and it’s hard to predict what might trigger someone, but if you know there are certain things, they should be avoided,” said Everett, now a section chief at Johns Hopkins Bayview Medical Center in Baltimore.—Richmond Times Dispatch


Here’s how to undo a caffeine tolerance…. In one experiment, Roland Griffiths, a drug researcher at Johns Hopkins, gave his subjects access to unlimited coffee of varying strengths and caffeine levels and observed how they spaced out their consumption.—New York magazine

Millions of adult women have ADHD. So why does it feel so lonely? …. “Women do get missed,” said Dr. David Goodman, an assistant professor in the department of psychiatry and behavioral sciences at Johns Hopkins School of Medicine and an expert in adult ADHD. And when ADHD is untreated, it can lead to many negative consequences, he added.—Huffington Post

(Letter to the editor) Md. prisons need a more enlightened approach to drug treatment.... The writer is Dr. Kenneth B. Stoller,an assistant professor at the Johns Hopkins University School of Medicine.—Baltimore Sun*

Link between exercise and brain health supported in new report.... “Knowing there is strong scientific evidence that physical activity impacts adults’ ability to stay mentally fit should encourage people to exercise more,” said Marilyn Albert, [the Global Council on Brain Health's] chairwoman and the director of the Division of Cognitive Neuroscience at Johns Hopkins University.—Pittsburgh Post-Gazette

Hopkins School of Medicine affiliate establishes prize to honor co-founder… The Lieber Institute for Brain Development, an affiliate of Johns Hopkins University School of Medicine and an independent, not-for-profit 501(c)(3) medical research institute, announced Thursday a new prize in the field of developmental neuroscience in memory of Constance Lieber, one of the institute’s founders. —Maryland Daily Record*

Why kicking the opioid habit can be so tough…None of this surprises addiction specialist Kelly Dunn, who researches the issue at the Johns Hopkins University School of Medicine, in Baltimore. "When you stop taking opioids it takes time for your body to regenerate its own 'painkiller' system," she explained. — Baltimore Sun* also in Chicago Tribune

Baltimore Magazine – July 2016
Care First
After losing her son to schizophrenia, Laura Pogliano keeps his memory alive by helping others.
JH Schizophrenia Center is mentioned and Krista Baker is quoted

The last sane drug on Earth fights for survival.... “In the U.S. big pharma is already pushing lithium out of the market,” Dr. Thomas Schulze of the Psychiatry and Behavioral Sciences department at Johns Hopkins, said. “They only want to market their own medications. There’s off-label use [like for schizoaffective disorder], but nobody has ever quite managed to rebrand lithium. You can’t patent that, you can’t re-release it.—Inverse

‘I’m sorry you were offended’ is not really an apology!.... [R]esearch points to an increase in the forgiveness-health connection as you age. “There is an enormous physical burden to being hurt and disappointed,” says Karen Swartz, M.D., director of the Mood Disorders Adult Consultation Clinic at The Johns Hopkins Hospital.—Psychology Today

Researchers homing in on the genetic causes of bipolar disorder.... Earlier studies examining the genetic cause of bipolar disorder focused on identifying common DNA changes that could only explain a small percentage of the risk for bipolar disorder. [Newly published] research, led by Dr. Fernando Goes of the Johns Hopkins University School of Medicine, instead focused on identifying more rare genetic mutations that are less common, but may be linked to the more severe forms of bipolar disorder.—Healthline

How psychedelic drugs could help treat addiction.... “People will often report a changed relationship in observing themselves [when using psychedelic drugs]. I think this is much like what we refer to as mindfulness: someone’s ability to view their own motivations and behavior from a more detached and less judgemental perspective,” said Matthew Johnson, a professor of psychology at Johns Hopkins University who is testing psilocybin in a trial aimed at nicotine addiction.—Motherboard

Researchers develop genetic test that can predict your risk of Alzheimer's disease…. [T]he latest effort at early detection is “an important first attempt,” said Johns Hopkins University’s Dr. Dimitrios Avramopoulos, who studies genes and mental illness and was not involved in the study. As genome-wide association studies become larger, and researchers’ gain confidence in identifying the true risk variants for Alzheimer’s Disease, “prediction will improve,” Avramopoulos added.—Los Angeles Times

Derrick Morgan doesn't want to get high, he wants to save his brain…. Morgan, [an NFL player], is mostly intrigued by further study of a non-psychoactive element in cannabis called cannabidiol, or CBD, which in very preliminary animal studies has shown the ability to protect and heal the brain. He has donated money toward two upcoming studies — to be conducted by researchers at Johns Hopkins and the University of Pennsylvania — meant to examine the impact of cannabis on current and former NFL players—USA Today

The fascinating, strange medical potential of psychedelic drugs, explained in 50+ studies…. "[Addiction, obsessive compulsive disorder, depression and end-of-life anxiety] are among the most debilitating and costly disorders known to humankind," Matthew Johnson, one of the psychedelics researchers at Johns Hopkins University, said. "We have some things that help, but for some people they’re barely scratching the surface, [and] for some people there’s nothing that helps at all."—Vox

CBD research for NFL players spurs “productive dialogue” with NFLPA…. Dr. Marcel Bonn-Miller, a professor of psychology at the University of Pennsylvania’s Perelman School of Medicine, and Dr. Ryan Vandrey, a professor of psychiatry and behavioral sciences at Johns Hopkins University, have teamed to study former players’ use and non-use of [cannabidiol] via detailed questionnaires, and to follow a group of current players throughout the season to track their injuries, recoveries and use of CBD and other pain relievers.—Denver Post


How pro-anorexia websites exacerbate the eating disorder epidemicAngela Guarda, director of the Eating Disorders Program at Johns Hopkins University, explains that there are three levels of causality in anorexia.—Newsweek

When the body attacks the mind....Some scientists now wonder whether small subsets of depression, schizophrenia, and bipolar disorder may be somehow linked to problems in the immune system.​�Robert Yolken, a scientist at Johns Hopkins University, estimates that about one-third of schizophrenics show signs of immune activation (though he adds that this could be related to other factors, such as smoking and obesity) .—The Atlantic

Fitbit’s newest feature reminds you to go to bed…. “Sleep Schedule” is focused on helping you meet your own, personalized sleep goals, [Fitbit] says…. The option was developed in collaboration with a panel of sleep experts, including Drs. Michael Grandner at the University of Arizona, Allison Siebern at Stanford University, and Michael Smith at Johns Hopkins University.—Tech Crunch Also: PC magazine

My mission after a depressive episode: Find joy again.... I remember the words of the psychiatric nurse when I was hospitalized at Johns Hopkins’ psychiatric unit. During group therapy one day, she had us all go around a circle and mention one thing that brought us joy — one activity that we loved to do when we were feeling well. “You will enjoy those things again,” she said. “You must trust me on that.”Everyday Health

Scientists, frustrated by funding shortfalls, launch institute for research on cannabinoids….“I’m super excited about [the institute],” said Ryan Vandrey, associate professor at Johns Hopkins University School of Medicine in Baltimore…. “We want to try to form a place where a state that is considering a new medical marijuana program can go to obtain expertise and data to inform their policies.—International Business Times

HR 2646: The families of the 4 percent speak out…. The common thread running through all these [families’] stories is anosognosia. Russell L. Margolis, M.D., the Clinical Director of Johns Hopkins Schizophrenia Center, says, “Anosognosia is a symptom of not knowing that you are ill. It is not uncommon in many individuals with severe mental illness. It is a major problem.”—Huffington Post

Push for CBD research gains notice from NFL.... “When the Bright Lights Fade” [was] launched to raise money for the initial studies — led by [Dr. Ryan] Vandrey at Johns Hopkins University and Bonn-Miller at the University of Pennsylvania — on CBD’s [cannabidiol's] potential efficacy in treating pain and even chronic traumatic encephalopathy (CTE), a degenerative brain disease linked to former NFL players and others with histories of repeated head trauma.—Denver Post

Live every day like you’re on mushrooms…. [Kathleen] Conneally was a participant in an addiction study conducted by researchers at Johns Hopkins University, who wanted to determine whether the relentless pull of nicotine could be weakened by another drug: psilocybin — the active compound in magic mushrooms. Conneally’s trip, the second in a series of three such “sessions,” was probably the best outcome the researchers could have hoped for.—The Atlantic

June1, 2016 – WYPR Midday | Facing Alzheimer’s Disease Jason Brandt joins the conversation - LISTEN

Prince died from potent prescription painkiller: Autopsy…. "Opioids are the gold standard for pain management," said Kelly Dunn, an assistant professor with the behavioral pharmacology research unit at the Johns Hopkins University School of Medicine in Baltimore. "And it's important not to vilify physicians who are genuinely treating patients who need them.—HealthDay and numerous subscribers

Can meditation and psychedelics have the same benefits for your mind?...."Meditation interventions have been shown to be effective in reducing stress and anxiety... it is a powerful and established method to alter human consciousness," said Frederick Barrett, a behavioral neuroscientist at Johns Hopkins University. His team focuses on practices that can affect human consciousness.—CNN

Mental health programs gaining momentum…. By the end of July, Johns Hopkins Hospital in Baltimore hopes to have six behavioral health teams working side-by-side with physicians and nurses to help manage the mental health of patients. The ambitious plan aims to prove that investing in behavioral health specialists is good for patients and the bottom line.—Health Leaders Medi

Researchers look for link between head trauma and Parkinson’s.... “We are working hard to figure that out [if repeated blows to the head and brain-related disorders are connected],” said Dr. Jennifer Coughlin, a physician at Johns Hopkins Hospital and an assistant professor at the Johns Hopkins School of Medicine. She is one of many researchers around the country turning to new technology to help solve the puzzle.—WTOP-FM (D.C.)

Reader’s Digest – June 2016
Myths About ADHD You Still Get Wrong – David Goodman clears the confusion about ADHD, a prevalent yet often misunderstood disorder.

The high life: Pot for pain.... With a little help from weed, Baltimore Raven Eugene Monroe is tearing through NFL hypocrisies. Last month, the Ravens' offensive tackle kicked off a campaign opposing NFL drug testing for pot, demanding the league consider using cannabinoids to treat chronic pain, and donated $80,000 to the University of Pennsylvania and Johns Hopkins University School of Medicine for medical cannabis research.—Baltimore City Paper

What’s the best way to talk to someone with Alzheimer’s? ...Christopher Marano, a geriatric psychiatrist at Johns Hopkins Medicine, said that the interval between the initial diagnosis and a significant downturn can range from five to 20 years but that “people who are diagnosed at a younger age tend to progress faster.”—Washington Post

FDA approves implant to battle opioid addiction…. The steady flow from the implant [probuphine​]will reduce fluctuations that can occur when taking a medication once or twice daily, and it removes the need for a patient to remember to take it, said Dr. Annie Umbricht, an expert in substance abuse treatment at Johns Hopkins University in Baltimore.—HealthDay

Lecture on trauma hits home for family who lost daughter in car crash.... Medical professional and interested parties alike gather to listen to a lecture on treating trauma…. Daniel Buccino, a clinical director at the Moods Disorder [Center] at Johns Hopkins Bayview Medical Center and an assistant professor at Johns Hopkins School of Medicine, weaves a delicate line between the stigmas that can pervade the field of psychiatric treatment and the successes effective treatment can have on patients.—Capital Gazette


Bright spot in treatment of heroin addiction…. An injectable drug … is offering new hope to those struggling with addiction. The drug [naltrexone]is the new standard of care for treating addiction, said Dr. Marc Fishman, assistant professor at the Johns Hopkins University School of Medicine and medical director of a Baltimore treatment center.—Delaware Online

Are kids really more likely to get high when marijuana is legal? ...“We have two years of data on what happens when you legalize cannabis,” said Ryan Vandrey, a behavioral pharmacologist with an expertise in cannabis at the Johns Hopkins School of Medicine. “I don’t think that’s long enough to fully understand and grasp the nature of change.”—Boston Globe

Swapping LSD for coffee at work is probably a bad idea.... Dr. Matthew Johnson, an associate professor of psychiatry at Johns Hopkins University and an expert on drug addiction, has been skeptical of the breathless media coverage of LSD microdosing from the beginning. He told The Daily Beast that there is “no evidence that this is a big thing.”—The Daily Beast

9 sneaky things that might be killing your sex drive…. “Over the course of time, we’re understanding it more [why it’s hard for women to get in the mood sometimes],” explains Kate Thomas, Ph.D., a director of clinical services in the sexual behaviors consultation unit at the Johns Hopkins Hospital. “With Addyi [the new female libido Rx], some women might respond to the medication, even though we don’t know why.”—Glamour

How an online community is boosting health in the real world…. One woman's quest for answers after a devastating diagnosis led to an online storytelling community where people can find the emotional support they need to feel better. Johns Hopkins neuropsychiatrist Dr. Adam Kaplin found this community improved some users’ outlook and even their health. “I was completely blown away. We saw an enormous increase in people’s purpose in life,” he says.—NBC News

LSD-like drugs are out of the haze and back in the labs....American research interest in psilocybin is especially keen. This is a psychoactive ingredient in the fungus family known as magic mushrooms. It helps that psilocybin carries little of the baggage that still burdens LSD, said Matthew W. Johnson, a professor of psychiatry and behavioral science at Johns Hopkins.—New York Times

Want to test a marijuana-based drug? Expect a visit from the ‘men in black’ ... It recently took Ryan Vandrey [a behavioral pharmacologist at Johns Hopkins Medicine] and other researchers six months to get the nod from the DEA for a clinical trial looking at cannabis as a possible therapy for veterans with post-traumatic stress disorder — and the agency had no comments on the proposed study itself, Vandrey said.—Stat

LSD-like drugs are out of the haze and back in the labs....American research interest in psilocybin is especially keen. This is a psychoactive ingredient in the fungus family known as magic mushrooms. It helps that psilocybin carries little of the baggage that still burdens LSD, said Matthew W. Johnson, a professor of psychiatry and behavioral science at Johns Hopkins.—New York Times

Pot candy manufacturer faces lawsuit over Denver death…. Consuming marijuana edibles may lead to a strong effect while maintaining low levels of THC in the blood, claims a report by Ryan Vandrey, a researcher of the effects of marijuana at Johns Hopkins University’s School of Medicine in Baltimore, Maryland.—RT (Russia)

Is addiction a brain disease? ... In so-called contingency management experiments, subjects addicted to cocaine or heroin are rewarded with vouchers redeemable for cash, household goods or clothes. Those randomized to the voucher arm routinely enjoy better results than those receiving treatment as usual. Consider a study of contingency management by psychologist Kenneth Silverman at Johns Hopkins.U.S. News & World Report

The latest prescription psychedelics idea? Treat addiction with magic mushrooms…. In a recent Johns Hopkins University study, 80 percent of heavy smokers treated with [psilocybin] were still cigarette-free six months after treatment. The best nicotine treatments available on the market today, on the other hand, have success rates of just 20 percent.—Huffington Post

History of yeast infection may increase risk of psychiatric disorders… Researchers from Johns Hopkins University have observed a link between yeast infections and a history of mental illness…. [They] caution that the association doesn’t prove a causal effect but that it may provide insight on how lifestyle, immune system weaknesses and gut-brain connections may affect an individual’s risk of psychiatric disorders and memory impairment.—Fox News


The Diane Rehm Show WAMU – April 25, 2016 – LISTEN OR DOWNLOAD
Suicide in America – panel included Holly Wilcox, Ph.D.

Hospitals test putting psychiatrists on medical wards.... Johns Hopkins Hospital in Baltimore in April launched a program to screen patients for psychological problems shortly after they are admitted. About 20% of the nearly 50,000 patients the hospital discharges a year have mental-health disorders in addition to their physical ailments, the hospital says.—Wall Street Journal* (Sign-in with USER: JohnsHopkins and PASSWORD: Medicine)

Correcting the Record: Leo Kanner and Autism…Pioneering researcher's work has been misrepresented. And Op-Ed by James Harris, MD, and Joseph Piven MD. MedPage Today

This opioid treatment model that provides all levels of care is spawning imitators…. Operated by Johns Hopkins Hospital and located two blocks from its main campus, the Broadway Center — or “911” as it’s called because of its address at 911 N. Broadway — has provided methadone maintenance therapy for people with opioid addiction for more than two decades.—Huffington Post

10 stories that capture what it’s like to struggle with depression…. 2. 6 things not to say to someone with depression. “Just think — there are others who have it worse than you do.” While you may be trying to put things into perspective, it may not be received that way. “[The key] is to recognize their suffering as opposed to being dismissive,” says Dr. Adam Kaplin, an associate professor in the departments of psychiatry and neurology at Johns Hopkins University.—Huffington Post

VIDEO | TedMed2016 | Roland Griffith, Ph.D. | The Science of Psilocybin and its Use to Relieve Suffering

Why you don’t sleep well in a strange bed…. While it's possible that the findings may explain poor sleep among frequent travelers, the study wasn't designed to test whether these "first night effects" continue to happen to people every time they hit the road, said Patrick Finan, a psychiatry and behavioral health researcher at Johns Hopkins University School of Medicine in Baltimore. "It is possible, for example, that frequent travelers might adapt to this first night effect over time," Finan, who wasn't involved in the study, said by email.— Reuters

DEA approves PTSD marijuana study…. Marcel Bonn-Miller with the University of Pennsylvania Perelman School of Medicine is now overseeing the project, with [Dr. Sue] Sisley running half the study in Arizona and Ryan Vandrey overseeing the other half at Johns Hopkins University in Baltimore, Maryland.—Military Times Also: Huffington Post

Can your genes make you kill? … “Genes are programs that run every activity of every cell in your body every second you are alive,” says Daniel Weinberger, director of the Lieber Institute for Brain Development at Johns Hopkins University. “If you inherit small glitches, little pieces of noise, this sets you on a path. But it doesn’t determine you will end up with mental illness. These glitches aren’t fate. They are for risk.—Popular Science

9 insightful stories only people with anxiety will understand…. People with anxiety are feeble. “Many people think that having this disorder means that they’re fearful or weak — and that’s certainly not the case,” says Joseph Bienvenu, an associate professor of psychiatry and behavioral sciences at Johns Hopkins University.—Huffington Post

Will Whoopi Goldberg’s pot-infused bath soak ease menstrual cramps?....“It’s possible to ingest too much or to ingest not enough,” said Ryan Vandrey, a public health researcher at Johns Hopkins University who has studied the potential risks of edibles and other medical marijuana products. Because such products are largely unregulated, the levels of THC can vary widely between brands. “There’s no guarantee in consistency of dosing from one product to the next,” he added.—Stat, PBS Newshour

LSD could make you smarter, happier and healthier. Should we all try it? … When we trip ... the boundaries between self and world, subject and object dissolve…. As Matthew Johnson, a principal investigator in Johns Hopkins’s psilocybin studies, explains, these [LSD] experiences include a “transcendence of time and space,” a sense of unity and sacredness and a deeply felt positive mood.— Washington Post


Psychiatric News – March 14, 2016
Seeing with the Mind’s Eye: A Profile of Barbara Young, M.D.

A grown-up approach to treating anorexia…. “The longer you have anorexia, the more anorexia creates physiological changes in the body and the brain that then create a self-sustaining cycle,” says Angela Guarda, Director of the Eating Disorders Program at Johns Hopkins University.—New Republic

Antipsychotics don't ease delirium in hospitalized patients.... Antipsychotic medications, such as haloperidol (Haldol) or clozapine (Clozaril), aren't appropriate for preventing or routinely treating delirium in hospitalized patients, a new study suggests. "The American Geriatrics Society guidelines suggest avoiding using these medications as a part of routine care of a patient with delirium," said lead researcher Dr. Karin Neufeld, clinical director of psychiatry at Johns Hopkins Bayview Medical Center in Baltimore.—​HealthDay, United Press International, Doctors Lounge

Mindful meditation may be the answer to relieving chronic back pain, study suggests…. In an editorial, Madhav Goyal and Jennifer A. Haythornthwaite of Johns Hopkins University School of Medicine said that the mechanisms for why meditation might work on back pain is still a mystery but that question is merely "academic" for many clinicians and their patients who need immediate relief.—Washington Post Also: HealthDay, LiveScience

Moms: Help needed for largest ever postpartum depression study…. To reach those women, researchers will be distributing iTouches to clinics around the country, 10 so far and counting, with institutions like the University of Arkansas, the University of Pennsylvania, Johns Hopkins University and Northwestern University committed to participate.—CNN

Patients in ecstasy clinical trial find drug beneficial.... FDA-approved studies with psilocybin, sponsored by the Heffter Research Institute and under way at Johns Hopkins University and New York University, are also focusing on psychological treatment of cancer patients.—San Francisco Chronicle

Raven Eugene Monroe promotes medical marijuana for football pain, non-athletes…. Monroe said he would donate $10,000 to the Realm of Caring Foundation, a 3-year-old nonprofit based in Colorado that works with hospitals, doctors and patients to collect data on cannabis products and to advocate for medical marijuana use. Dr. Ryan Vandrey, an associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, works with the foundation.—Baltimore Sun*​, Also: WBFF-TV

3 ways to end bedtime procrastination (for good)…. Turning on a noise machine at the time you know you should start getting ready for bed….. "In addition to drowning out noises that might keep you up, white noise works on a deeper psychological level, conditioning you to associate the noise with bedtime," says David Neubauer, MD, associate professor of psychiatry and behavioral sciences at Johns Hopkins Medicine.Huffington Post

Centers to Treat Eating Disorders Are Growing, and Raising Concerns….. “For the most part, the people who are running and working in these programs believe they’re doing the right thing,” said Dr. Angela Guarda, the director of the eating disorders program at the Johns Hopkins Hospital in Baltimore. “But it’s a slippery slope,” she said. “Money can cloud your view.” - New York Times

What to look for in an eating disorder treatment center.... Place a priority on therapies that focus on behavior, rather than on identifying the roots of the eating disorder. “Unless you can change the behavior, no amount of insight-oriented therapy is helpful,” said Dr. Angela Guarda, the director of the eating disorders center at the Johns Hopkins Hospital in Baltimore.—New York Times

Marijuana-based drug found to reduce epileptic seizures…. GW [Pharmaceuticals] executives say that an approved pharmaceutical should be favored by doctors and patients because the other medical marijuana products have not gone through the same rigorous vetting. A study last year by researchers at Johns Hopkins University and elsewhere found that medical marijuana products rarely contained the amount of ingredients stated in their labels.—New York Times

(Opinion) Brain injury: A public health crisis in the spotlight.... For the millions of Americans suffering from the effects of [traumatic brain injury] there is a moral and economic imperative to accelerate efforts not only to find ways to prevent brain injuries, but also to improve the lives of individuals who suffer from them. (Note: This opinion piece was written by Daniel R. Weinberger, director and CEO of the Lieber Institute for Brain Development at the Johns Hopkins School of Medicine and Professor of Psychiatry, Neurology, Neuroscience and Human Genetics.—The Hill

CDC opioid prescribing guidelines unlikely to affect physicians' practices…“Unfortunately, I'm not sure that the people who are prescribing these medications long-term are going to heed the pretty practical advice that's provided by the Centers for Disease Control and Prevention,” said Dr. Una McCann, professor of psychiatry at Johns Hopkins Medicine – Modern Healthcare

A Call for Better Awareness and Diagnosis of ADHD in Older Adults… Both health care providers and patients need to be better informed about the prevalence of ADHD in people over 50. Op-ed by David Goodman, M.D. – US News and World Report

Psychiatric symptoms speed conversion to dementia.... Neuropsychiatric symptoms (NPS) are associated with more rapid progression from mild cognitive impairment to Alzheimer's disease, two new studies confirm. The first study, led by Sarah Forrester, a doctoral candidate at Johns Hopkins University, in Baltimore, Maryland, pinpoints clusters of NPS associated with faster progression.—Medscape

What Amnesia Tells Us About Memory - Sheilah Kast on WYPR MIDDAY interviews Dr. Jason Brandt. - WYPR

Why you need more sleep tonight…. Waking up in the middle of the night shortens your fuse. Spending all night tossing and turning can cause you to wake up on the wrong side of the bed, says a study from Johns Hopkins Medicine (Dr. Patrick Finan).—Family Circle


30-Year Amnesia: How the Brain Suddenly Remembers…. Although amnesia is a clichéd plot device for mystery novels and soap operas, this type of global amnesia — in which a person forgets everything about his or her life, typically called a fugue state — is very rare, said Jason Brandt, a neuropsychologist at Johns Hopkins School of Medicine in Baltimore, who was not involved in Latulip's care. – Live science

Hall of Fame recognizes Cody Unser’s role in diving, disability communities.... Dr. Adam Kaplin, neuroscientist and principal psychiatric consultant to the Johns Hopkins Department of Neurology, was the lead investigator for [a study that showed some divers with disabilities experienced improvement in sensation, tone or motor function]. Kaplin wrote a letter recommending Unser for the [Women Divers] Hall of Fame.—Albuquerque Journal

Filmmaker Paul Dalio mines his bipolar disorder for feature debut​....Dalio sat down recently to talk about the film, along with Kay Redfield Jamison, a professor of psychiatry at Johns Hopkins University whose book about the link between creativity and manic-depression lends the film its title.—Washington Post

New techniques, hope for treatment of eating disorders....“These are important public health problems,” says Dr. Graham Redgrave, assistant director of the Eating Disorders Program at Johns Hopkins. He says it’s crucial to identify people who are suffering — which is the theme of National Eating Disorders Awareness Week, which runs through Saturday.—WTOP-FM (D.C.)

Zika may increase risk of mental illness, researchers say….[T]he hallucinations, voices and paranoia of true schizophrenia do not normally emerge until late adolescence, “when there is a lot of rearranging and pruning in the brain,” said Dr. Robert H. Yolken, a developmental neurovirologist at Johns Hopkins University, who … believes that Zika increases mental illness risk.—New York Times

Medical marijuana increasingly legal, but trustworthy? A call for regulations.... Prof. Ryan Vandrey of the Johns Hopkins School of Medicine says his research has found that the majority of edible cannabis products, a growing trend, had their THC dosage mislabelled by more than 10 percent in California and Washington.—Christian Science Monitor

Study links concussion to higher risk of later suicide.... [L]oved ones should not be shy about watching for warning signs of suicide and urging past concussion victims to get help if needed, said Dr. Vani Rao, an associate professor of psychiatry and behavioral sciences and director of the brain injury program at Johns Hopkins Medicine in Baltimore.—U.S. News & World Report

Dog DNA probed for clues to human psychiatric ills …. Gerald Nestadt, a psychiatrist who specializes in OCD at Johns Hopkins University in Baltimore, Maryland, notes that affected animals often display only one type of compulsive behavior, whereas a human with OCD will typically have several. Nature

The Buzz on Death Wish Coffee….“People should be aware of the effects of getting too much caffeine. It varies from individual to individual, but consuming more than your normal amount could make you feel nervous, anxious, irritable, or jittery, and may cause excessive urine production or irregular heartbeat,” says caffeine researcher Maggie Sweeney, Ph.D., postdoctoral research fellow at the behavioral pharmacology research unit in the department of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine.—Consumer Reports

City Paper – February 9, 2016
Most Wanted: JHU students clamor to get into Dr. Kraft's 'Human Sexuality' class

This antidepressant may be no better than cheaper alternatives. But demand could soon soar.... “I don’t want to start someone on something and know that they’re not going to be able to afford more than a week of it,” said Dr. Christopher Marano, a psychiatrist at Johns Hopkins University School of Medicine who specializes in treating depression in the elderly. “From my perspective, I don’t see any reason to jump right to Brintellix as a first-line agent right now.”—Stat News

Immune system gene leads to schizophrenia clue…. Dimitrios Avramopoulos of Johns Hopkins University says that while the evidence for C4-related pruning in schizophrenia is interesting, it’s “not undisputable proof at this point.” He says more work is needed to be confident that the results are solid.—Science News


Dog DNA probed for clues to human psychiatric ills …. Gerald Nestadt, a psychiatrist who specializes in OCD at Johns Hopkins University in Baltimore, Maryland, notes that affected animals often display only one type of compulsive behavior, whereas a human with OCD will typically have several. Nature

Undiagnosed ADHD in adults is possible -- how to cope​....Dr. David Goodman, a ADHD specialist at Johns Hopkins School of Medicine, said that he had encountered a lot of ADHD cases in adults that are more than 50-years old. Though these are newly-diagnosed cases, their disorder probably started when they were still 7-years old. Goodman added that ADHD may start at a very young age but the symptoms may last a lifetime….—Latinos Health

Cocaine causes your brain to literally eat itself, study finds…. We know cocaine's not so good for your brain, but it turns out the effects of the popular drug are more gruesome than we thought. A new study from Johns Hopkins University finds that high doses of cocaine cause your brain cells to kill themselves. —Huffington Post Also: Youth Health, The Guardian (U.K.)

Cocaine causes brain cells to cannibalize themselves…. New research [at Johns Hopkins University] finds clues that cocaine actually causes brain cells to cannibalize themselves. This process, known in scientific terms as overactive autophagy, means that when neurons are exposed to cocaine, the brain actually digests itself.—Newsweek Also: Philadelphia Inquirer, Newser, Examiner

New medications for treating opioid addiction are on the horizon…. "Buprenorphine is a way to withdraw someone from opiates," says Dr. David Pickar, a psychiatrist at the Johns Hopkins University School of Medicine on [a FDA] advisory committee…. "The idea of not having any opiates in your body is very disturbing to some. The buprenorphine will help bridge that.—NPR and numerous affiliates

F.T.C.’s Lumosity penalty doesn’t end brain training debate…. George Rebok, a developmental psychologist at Johns Hopkins, is quoted twice in this article, standing with researchers who believe “certain cognitive training regimens can significantly improve cognitive function.”—New York Times

Can't focus? It might be undiagnosed adult ADHD…. [Cathy] Fields was diagnosed with ADHD about eight years ago. Her doctor ruled out any physical problems and suggested she see a psychiatrist. She went to Dr. David Goodman at Johns Hopkins School of Medicine, who by chance specializes in ADHD.... Goodman decided that Fields most definitely had ADHD.—NPR and numerous affiliates

Testing street drug and more, scientists seek fast-acting anti-depressant.... Promising new research from Johns Hopkins University this month pinpoints a compound that could treat symptoms of depression within hours — and targets the condition in a whole new way, offering hope to patients who haven’t benefited from traditional drugs.—Stat News

Opioid addiction and treatment.... At a House bipartisan task force on opioid addiction,Jessica Peirce, Ph.D., addiction treatment services associate directorat Johns Hopkins Bayview Medical Center, offered three ways to improvement treatment for addicts.—CSPAN​